{"study_id": 22253, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness of laughter yoga in reducing premenstrual syndrome (PMS) symptoms in women.", "results_summary": "The laughter yoga group showed significant reductions in multiple PMS symptoms, including depressive affection, anxiety, fatigue, irritability, depressive thoughts, pain, sleep changes, and bloating. Fatigue and pain scores were significantly lower in the laughter yoga group compared to the control group postintervention.", "population_specificity": "80 female nursing and midwifery students with PMS at Marmara University, Istanbul, Turkey.", "effective_dosage": "Twice-weekly 30-minute group sessions of laughter yoga and deep breathing.", "study_duration": "The intervention lasted from February 2019 to May 2020 (approximately 15 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:14.863350+00:00"}
{"study_id": 22255, "supplement_id": 1278, "safety_score": "90", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether laughter yoga could alleviate chemotherapy-induced nausea and vomiting in cancer patients.", "results_summary": "The study found a statistically significant decrease in the severity and duration of nausea in the laughter yoga group, but no significant difference in vomiting conditions between the intervention and control groups.", "population_specificity": "69 cancer patients undergoing chemotherapy at the Reza Chemotherapy and Oncology Center, Mashhad, Iran.", "effective_dosage": "Four 20-min to 30-min laughter yoga sessions.", "study_duration": "Sessions were held immediately before one of their chemotherapy appointments.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:15.583368+00:00"}
{"study_id": 22256, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to examine the effects of laughter yoga on perceived stress, positive psychological capital, and exercise capacity in lung cancer patients undergoing chemotherapy.", "results_summary": "Laughter yoga significantly improved positive psychological capital and exercise capacity, with discernible reductions in perceived stress compared to the control group. The effects were statistically significant with moderate to large effect sizes.", "population_specificity": "84 lung cancer chemotherapy patients from a general hospital in central China (80 completed the trial).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:17.034203+00:00"}
{"study_id": 22260, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to synthesize evidence on comedy/humour interventions and evaluate their impact on mental health recovery using the CHIME framework.", "results_summary": "The study found that comedy/humour interventions positively impacted mental health symptoms and several CHIME recovery mechanisms, including connectedness, hope, identity, and empowerment. Potential mechanisms for change included laughter, social interaction, and cognitive flexibility.", "population_specificity": "Adults with self-reported distress or a self-reported/diagnosed mental health condition.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:18.855097+00:00"}
{"study_id": 22259, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to examine the effects of laughter therapy on perceived stress and quality of life in persons with schizophrenia, as well as their views on the therapy.", "results_summary": "Laughter therapy significantly improved quality of life in interpersonal relations, instrumental role, and intrapsychic subscales but did not significantly affect perceived stress. Participants reported positive themes like optimism, coping, and sociability.", "population_specificity": "Persons with schizophrenia (68% male, 92% single, 60% unemployed, 88% receiving treatment for over 10 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:19.042331+00:00"}
{"study_id": 22258, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to explore the effects of laughter therapy on negative emotions (depression, anxiety, stress, pain, and fatigue) in cancer patients.", "results_summary": "Laughter therapy showed positive effects on improving emotional responses, including reductions in anxiety, stress, pain, fatigue, and depression in cancer patients. The therapy was deemed convenient and flexible, with benefits regardless of gender, age, or cancer type.", "population_specificity": "Cancer patients (no specific subtype or stage mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:19.048962+00:00"}
{"study_id": 22261, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of laughter yoga on quality of life and sleep quality in individuals with fecal ostomies.", "results_summary": "Laughter yoga significantly improved sleep quality (measured by PSQI scores) but did not significantly affect quality of life (measured by Stoma-QOL scores) in individuals with fecal ostomies. The control group showed no significant changes in either measure.", "population_specificity": "Individuals with fecal ostomies receiving care at a stoma therapy unit in Turkey.", "effective_dosage": "Weekly laughter yoga sessions.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:19.339477+00:00"}
{"study_id": 22262, "supplement_id": 1278, "safety_score": "90", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and feasibility of distance laughter therapy for reducing depression, anxiety, and parental stress in mothers caring for young children during the COVID-19 pandemic.", "results_summary": "Both laughter therapy and the control (TV show) groups showed significant reductions in depression and anxiety, but only the laughter therapy group experienced a significant reduction in parental stress. However, the differences between groups were not statistically significant. Participants reported positive changes in physical, emotional, social, self-perception, and stress-coping domains.", "population_specificity": "Mothers caring for young children during the COVID-19 pandemic.", "effective_dosage": "Four virtual sessions over two weeks.", "study_duration": "Two weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:22.685530+00:00"}
{"study_id": 22264, "supplement_id": 1278, "safety_score": "100", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of Laughter Yoga on the health-related quality of life of cancer patients undergoing chemotherapy.", "results_summary": "The study found that Laughter Yoga significantly improved emotional, physical, and role functioning, reduced fatigue, pain, and sleep disturbance, and enhanced global health and quality of life in cancer patients undergoing chemotherapy, with no adverse events reported.", "population_specificity": "Cancer patients undergoing chemotherapy at Reza Radiotherapy and Oncology Center, Iran.", "effective_dosage": "Four sessions at one-week intervals, each lasting 20-30 minutes.", "study_duration": "Four weeks (one session per week).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:23.763326+00:00"}
{"study_id": 22263, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between gelastic seizures (uncontrolled laughter) and a rare brain tumor (ganglioglioma) in a pediatric patient.", "results_summary": "The study found that gelastic seizures in the patient originated from the anterior temporal/inferior frontal region and were successfully controlled with Levetiracetam, followed by surgical removal of the tumor, resulting in seizure freedom at 3-year follow-up.", "population_specificity": "An 8-year-old ambidextrous patient with a low-grade ganglioglioma in the temporal lobe.", "effective_dosage": "Not specified", "study_duration": "Not specified (intervention included medication and surgery)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:24.336317+00:00"}
{"study_id": 22265, "supplement_id": 1278, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of spontaneous laughter on stress response by measuring changes in cortisol levels through a systematic review and meta-analysis of interventional studies.", "results_summary": "The study found that spontaneous laughter interventions significantly reduced cortisol levels by 31.9% compared to control groups, with even a single laughter session showing a 36.7% reduction. These results were consistent across randomized controlled trials and quasi-experimental studies.", "population_specificity": "Adults (mean age 38.6 years).", "effective_dosage": "Varied\u2014five studies used humor/comedy videos, two used laughter sessions with a therapist, and one used a self-administered laughter program.", "study_duration": "Not specified (some interventions involved single sessions).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:26.317566+00:00"}
{"study_id": 22268, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether laughter yoga could improve psychological resilience and sleep quality in nurses during the COVID-19 pandemic.", "results_summary": "Laughter yoga significantly improved resilience levels and sleep quality in the experimental group compared to the control group (P < .05).", "population_specificity": "Nurses working in a hospital in Erzurum, Turkey.", "effective_dosage": "Eight sessions of laughter yoga (two days a week for four weeks).", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:26.377382+00:00"}
{"study_id": 22266, "supplement_id": 1278, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if laughter yoga could reduce state anxiety, perceived stress, and improve self-confidence and satisfaction in undergraduate nursing students before simulation training.", "results_summary": "Laughter yoga significantly reduced state anxiety, perceived stress, pulse rate, and arterial pressure while increasing self-confidence and satisfaction in learning compared to the control group. Vital signs also improved in the intervention group.", "population_specificity": "Undergraduate nursing students in Turkey (n=88).", "effective_dosage": "Not specified (laughter yoga sessions before simulation training).", "study_duration": "Data collected over two months (January - February 2022).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:26.438806+00:00"}
{"study_id": 22267, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a 12-week laughter yoga program could improve glycemic control in individuals with type 2 diabetes.", "results_summary": "The laughter yoga group showed significant improvements in HbA1c levels and positive affect scores, with a trend toward increased sleep duration. The program had a high attendance rate (92.9%), indicating feasibility.", "population_specificity": "42 participants with type 2 diabetes.", "effective_dosage": "12-week laughter yoga program (frequency not specified).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:26.622495+00:00"}
{"study_id": 22269, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how laughter yoga impacts loneliness, psychological resilience, and quality of life in older adults living in a nursing home.", "results_summary": "The study found that an eight-session laughter yoga program significantly reduced loneliness and increased psychological resilience and quality of life in older adults, with statistically significant differences between the intervention and control groups.", "population_specificity": "Older adults (n=65) living in a nursing home in Turkey.", "effective_dosage": "Twice a week for four weeks.", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:26.682041+00:00"}
{"study_id": 22270, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of online laughter therapy on depression, anxiety, stress, and loneliness levels in first-year nursing students during the COVID-19 pandemic.", "results_summary": "Online laughter therapy significantly reduced depression levels but had no significant effect on anxiety, stress, or loneliness. The intervention group showed statistically significant improvement in depression compared to the control group.", "population_specificity": "First-year nursing students transitioning to distance education during the COVID-19 pandemic.", "effective_dosage": "Twice weekly for four weeks.", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:30.205359+00:00"}
{"study_id": 22271, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers described a case of headaches associated with laughter in a child with Chiari Type 1 Malformation, focusing on diagnosis and management.", "results_summary": "The study found that laughter triggered headaches in a child with Chiari Type 1 Malformation, diagnosed via MRI. The patient was managed conservatively with monitoring, as pediatric cases often show symptom improvement without surgery.", "population_specificity": "A 5-year-old boy with Chiari Type 1 Malformation.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:31.297828+00:00"}
{"study_id": 22272, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the effect of laughter therapy on mood disturbances and pain in terminally ill cancer patients and mood disturbances and burnout levels in their family caregivers.", "results_summary": "Laughter therapy significantly reduced mood disturbances in patients and caregivers, pain in patients, and burnout levels in caregivers. The intervention group showed statistically significant improvements compared to the control group.", "population_specificity": "Terminally ill cancer patients and their family caregivers in a hospice ward.", "effective_dosage": "20 to 30 minutes a day for 5 consecutive days.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:32.206666+00:00"}
{"study_id": 22275, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of online laughter therapy on anxiety, life satisfaction, and psychological well-being in nursing students.", "results_summary": "Online laughter therapy significantly increased life satisfaction and psychological well-being scores and significantly decreased anxiety scores in the intervention group compared to the control group.", "population_specificity": "Senior nursing students (n=80, split into intervention and control groups).", "effective_dosage": "Ten sessions of online laughter therapy, two days a week.", "study_duration": "Five weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:33.770458+00:00"}
{"study_id": 22273, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of simulated laughter therapy on physical symptoms, pulmonary function, depression, and health-related quality of life in pulmonary tuberculosis patients.", "results_summary": "Laughter therapy significantly reduced physical symptoms and depression while improving pulmonary function and health-related quality of life in tuberculosis patients, with no such improvements observed in the control group. Group differences in these outcomes were statistically significant.", "population_specificity": "Pulmonary tuberculosis patients (n = 52, split into experimental and control groups).", "effective_dosage": "Twice a week in 60-minute group sessions.", "study_duration": "Eight weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:33.885824+00:00"}
{"study_id": 22274, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the underlying causes, diagnostic criteria, and treatment options for pathological laughter and crying, focusing on its association with central nervous system damage.", "results_summary": "The study found that pathological laughter and crying is linked to disruptions in central nervous system pathways, with evidence supporting the effectiveness of dextromethorphan and quinidine, and weaker evidence for antidepressants like tricyclics and SSRIs. The condition is underdiagnosed but treatable.", "population_specificity": "Individuals with pathological laughter and crying due to neurodegenerative diseases, CNS inflammation, vascular lesions, or traumatic brain injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:34.827487+00:00"}
{"study_id": 22276, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether laughter could stimulate large-scale brain networks, particularly the left frontotemporal network, to potentially remediate affective symptoms like depression.", "results_summary": "The study found significant differences in happy facial expressions, physiological responses (heart rate variability, muscle activity), and eye-tracking metrics when participants watched funny videos compared to neutral ones. EEG data showed increased activity in the left frontotemporal network during laughter, suggesting it as a potential target for neuromodulation in affective disorders.", "population_specificity": "25 healthy individuals", "effective_dosage": "Not specified (standardized funny video clips)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:35.937120+00:00"}
{"study_id": 22277, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to investigate the effects of a 12-week laughter program on physical (body weight, BMI) and psychological (stress, well-being, HRQOL) outcomes in Japanese community-dwelling individuals with metabolic syndrome risk factors.", "results_summary": "The laughter program significantly improved body weight, BMI, subjective stress, well-being, optimism, and physical HRQOL scores. Participants who reduced BMI also showed improved physical HRQOL, suggesting stress reduction and mental health benefits may contribute to weight management.", "population_specificity": "Japanese community-dwelling adults aged 43-79 years (mean 66.9), predominantly women (198/235), with metabolic syndrome risk factors.", "effective_dosage": "Not specified (program included laughter yoga and other components).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:37.194621+00:00"}
{"study_id": 22279, "supplement_id": 1278, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the efficacy of laughter-inducing interventions in treating somatic or mental health conditions through a meta-analysis of randomized controlled trials.", "results_summary": "Laughter-inducing interventions showed significant positive effects on mental health, physiological, and physical health outcomes, with moderate to large effect sizes. Adverse events were rare and mild when reported.", "population_specificity": "Somatic or mental health patients (2,547 randomized participants across 45 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:38.064555+00:00"}
{"study_id": 22278, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to understand what constitutes a good experience of care for inpatient children and young people with intellectual disability as perceived by nursing staff.", "results_summary": "The study identified key themes for safe care, including rapport, trust, and shared learning, and extended the conceptual model with new themes like the unique role of pediatric nurses and joy in job satisfaction. The findings emphasized the importance of partnership between nursing staff, patients, and families in delivering safe care.", "population_specificity": "Inpatient children and young people with intellectual disability and nursing staff from specialty neurological/neurosurgical and adolescent medicine wards in Australian tertiary children's hospitals.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:38.482568+00:00"}
{"study_id": 22280, "supplement_id": 1278, "safety_score": "95", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate laughter therapy as a non-pharmacological intervention to reduce stress, anxiety, and depression during the COVID-19 pandemic.", "results_summary": "The study found that laughter therapy can physiologically reduce pro-stress factors and increase mood-elevating anti-stress factors, making it a useful supplementary therapy to alleviate mental health burdens during the pandemic.", "population_specificity": "General population affected by COVID-19-related stress (no specific demographic details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:39.334720+00:00"}
{"study_id": 22282, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of laughter therapy on acculturative stress, anxiety, depression, and salivary biomarkers in married immigrant women in South Korea.", "results_summary": "The laughter therapy program significantly reduced acculturative stress, anxiety, depression, and salivary cortisol levels, but did not significantly affect salivary IgA levels compared to the control group.", "population_specificity": "Married immigrant women in South Korea", "effective_dosage": "Twice a week for 2 weeks", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:40.610075+00:00"}
{"study_id": 22281, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to examine the effect of progressive muscle relaxation exercises and laughter therapy on the mental health and treatment outcomes of women undergoing IVF.", "results_summary": "Laughter therapy combined with progressive muscle relaxation reduced depression and trait anxiety scores in women receiving IVF treatment, with small to large effect sizes, but did not affect medical outcomes such as pregnancy rates.", "population_specificity": "Women undergoing in vitro fertilization (IVF) treatment at a private IVF center.", "effective_dosage": "40-minute sessions, 3-4 sessions total.", "study_duration": "Sessions were conducted during the IVF treatment period, up to the oocyte pick-up day.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:41.832884+00:00"}
{"study_id": 22283, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether laughter therapy could improve happiness levels and self-esteem in 5th-grade students.", "results_summary": "Laughter therapy significantly increased happiness levels in students but had no effect on self-esteem. The intervention group showed statistically significant improvements in happiness compared to the control group.", "population_specificity": "5th-grade students at a secondary school in Turkey (29 in the intervention group, 32 in the control group).", "effective_dosage": "Twice a week", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:42.112023+00:00"}
{"study_id": 22285, "supplement_id": 1278, "safety_score": "90", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the therapeutic potential of laughter therapy, particularly in diabetes care, by reviewing existing evidence.", "results_summary": "The study highlights that laughter therapy has multifaceted physiological and endocrine benefits and is being used to manage various chronic diseases, including diabetes. However, specific efficacy data or clinical outcomes are not detailed in the abstract.", "population_specificity": "Patients with chronic diseases, particularly diabetes (not further specified).", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:44.500554+00:00"}
{"study_id": 22288, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether laughter therapy could improve life satisfaction and reduce loneliness in older adults living in nursing homes.", "results_summary": "The study found a statistically significant reduction in loneliness scores in the experimental group compared to the control group after 6 weeks of laughter therapy, suggesting it may effectively reduce loneliness in older adults.", "population_specificity": "Older adults living in nursing homes", "effective_dosage": "Twice a week", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:45.191983+00:00"}
{"study_id": 22286, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of laughter yoga on plasma beta-endorphin levels, pain levels, and sleep quality in hemodialysis patients.", "results_summary": "Laughter yoga significantly reduced pain levels and improved sleep quality in the intervention group, but no significant change was observed in beta-endorphin levels.", "population_specificity": "Hemodialysis patients (n=68) from two dialysis centers.", "effective_dosage": "30-minute sessions, twice weekly (total 16 sessions).", "study_duration": "Approximately 8 weeks (July to October 2018).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:45.881488+00:00"}
{"study_id": 22289, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of laughter yoga on mental symptoms and cortisol levels in nursing students.", "results_summary": "The study found a significant decrease in mental symptom scores and cortisol levels in the intervention group compared to the control group, suggesting laughter yoga can help reduce stress and mental symptoms.", "population_specificity": "First-year nursing students (75 healthy university students).", "effective_dosage": "Not specified (laughter yoga sessions).", "study_duration": "8 sessions.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:46.836105+00:00"}
{"study_id": 22290, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the feasibility of prescribing laughter and its potential effects on sleep, wellbeing, and psychological health in university students.", "results_summary": "The study assessed feasibility but did not report specific efficacy results; it planned to measure sleep outcomes, wellbeing, and psychological health using actigraphy and validated scales.", "population_specificity": "University students", "effective_dosage": "1-minute laughter recording (Laughie) three times daily", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:47.559005+00:00"}
{"study_id": 22291, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of a simulated laughter intervention on cortisol and BDNF levels in schizophrenia patients and assess whether these effects persisted after discontinuation.", "results_summary": "The laughter group showed significantly higher BDNF levels after 8 weeks, but levels dropped post-intervention. Cortisol levels remained unchanged at week 8 but significantly increased by week 12. The control group showed no significant changes in BDNF or cortisol levels.", "population_specificity": "Patients with schizophrenia (DSM-IV criteria)", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:49.290198+00:00"}
{"study_id": 22293, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of laughter therapy on depression and quality of life in elderly individuals living in nursing homes.", "results_summary": "Laughter therapy significantly reduced depression scores and improved quality of life dimensions in the intervention group, with statistically significant differences observed before and after the intervention.", "population_specificity": "Elderly individuals (over 60 years old) living in Abadeh nursing homes, without blindness, deafness, or significant physical/mental problems.", "effective_dosage": "Not specified", "study_duration": "July to September 2017 (approximately 2-3 months)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:51.822054+00:00"}
{"study_id": 22284, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to improve understanding of urinary incontinence during laughter by comparing children with daytime urinary incontinence (DUI) occurring during laughter to those with DUI at other times.", "results_summary": "The study found that children with DUI commonly experience incontinence during laughter, but true giggle incontinence is rare. Correct diagnosis is essential as it directs treatment.", "population_specificity": "Children with daytime urinary incontinence presenting to a tertiary continence service from 2017 to 2018.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:52.433826+00:00"}
{"study_id": 22295, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the impact of laughter yoga (LY) on depression and anxiety among retired women.", "results_summary": "The study found a significant difference in depression and anxiety scores between the intervention and control groups, with LY showing effectiveness in reducing these symptoms. The effects were statistically significant (p < .001) at weeks 4 and 8.", "population_specificity": "Retired women in Bojnurd, Iran.", "effective_dosage": "Twice weekly LY sessions.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:52.926115+00:00"}
{"study_id": 22294, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to measure the effect of intradialytic group laughter therapy on depressive symptoms in people undergoing hemodialysis.", "results_summary": "The study found that group laughter therapy significantly reduced depressive symptoms in hemodialysis patients, with fewer patients reporting symptoms post-intervention compared to controls. No differences were observed for anxiety, subjective well-being, or patient-reported dialysis symptoms.", "population_specificity": "Prevalent hemodialysis patients in 10 centers in Northern California.", "effective_dosage": "Once weekly, 30-minute group laughter therapy sessions.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:52.927341+00:00"}
{"study_id": 22297, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a single session of laughter yoga could attenuate the autonomic, endocrine, and psychological stress response compared to relaxation breathing and a non-intervention control.", "results_summary": "Laughter yoga did not affect subjective stress or salivary alpha amylase but significantly attenuated the cortisol stress response compared to relaxation breathing and the control group. The study suggests laughter yoga may help buffer endocrine stress responses.", "population_specificity": "35 healthy subjects (51% female)", "effective_dosage": "Single 30-minute session", "study_duration": "30 minutes", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:55.008438+00:00"}
{"study_id": 22296, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers were attempting to diagnose and treat a case of steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT) in a patient presenting with neuropsychiatric symptoms.", "results_summary": "The study found that steroid treatment was effective in managing SREAT symptoms, though the patient relapsed when steroids were discontinued. Prolonged steroid treatment with gradual dose reduction led to sustained symptom remission.", "population_specificity": "A previously healthy man in his late twenties with acute neuropsychiatric symptoms.", "effective_dosage": "Not specified", "study_duration": "Prolonged steroid treatment over a year, with follow-up 18 months after discontinuation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:55.089238+00:00"}
{"study_id": 22298, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of a Laughter Program on psychological stress and subjective happiness in Korean student nurses experiencing employment stress.", "results_summary": "The Laughter Program significantly reduced psychological stress (p < 0.001), lowered salivary cortisol levels (p < 0.001), and increased subjective happiness (p < 0.001) in student nurses.", "population_specificity": "4th-year student nurses (n = 48) from two universities in Korea.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:56.299613+00:00"}
{"study_id": 22292, "supplement_id": 1278, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effectiveness of laughter yoga on physical function and psychosocial outcomes in older adults.", "results_summary": "The study found significant improvements in physical function (blood pressure, cortisol levels, sleep quality) and psychosocial health (life satisfaction, quality of life, loneliness, death anxiety, depression, mood, happiness) in older adults practicing laughter yoga.", "population_specificity": "Older adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:59.259020+00:00"}
{"study_id": 22300, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether mirthful laughter from comic relief could influence pain tolerance and muscle soreness in young healthy participants.", "results_summary": "Watching a comedy video increased positive affect and maintained pain tolerance, while watching a documentary decreased both positive affect and pain tolerance. The comedy video elicited a significantly greater irregular breathing pattern compared to the documentary.", "population_specificity": "Young healthy participants (n=40)", "effective_dosage": "30 minutes of comedy video", "study_duration": "Single session (30 minutes)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:24:59.575221+00:00"}
{"study_id": 22299, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of laughter yoga compared to anti-anxiety medication in reducing anxiety and gastrointestinal symptoms in patients with IBS.", "results_summary": "Laughter yoga was more effective than anti-anxiety medication in reducing IBS symptoms, with a statistically significant difference (p = 0.006). Anxiety severity decreased in all groups, but the difference was not statistically significant (p = 0.1).", "population_specificity": "60 patients with IBS diagnosed via ROME III criteria, recruited from a GI clinic in Iran.", "effective_dosage": "Not specified", "study_duration": "April 2017 to March 2017 (exact intervention duration unclear)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:00.005875+00:00"}
{"study_id": 22301, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of laughter therapy on anxiety levels through a meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found that laughter therapy significantly decreased anxiety levels, with a standardized mean difference of -1.144 (95% CI, -1.950 to -0.338), indicating it is an effective complementary method for reducing anxiety.", "population_specificity": "157 participants across four randomized controlled trials (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:00.805684+00:00"}
{"study_id": 22302, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the benefits of integrative laughter therapy (ILT) on self-esteem, anxiety, and happiness in patients with addictive disorders receiving standard treatment at a day hospital.", "results_summary": "Both groups showed significant improvements in self-esteem and happiness with reduced anxiety, but the group receiving ILT alongside standard treatment demonstrated significantly greater improvements. The findings suggest ILT may enhance standard treatment outcomes for addiction patients.", "population_specificity": "Patients with addictive disorders treated at a day hospital.", "effective_dosage": "Weekly ILT sessions (exact duration per session not specified).", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:01.477459+00:00"}
{"study_id": 22303, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the use of humor in psychotherapeutic relationships and its effects on physical and psychological well-being.", "results_summary": "The study found that humor has beneficial effects on both physical and psychological well-being, though it also noted potential negative effects in therapeutic contexts. The abstract reviews existing studies but does not present new experimental data.", "population_specificity": "Not specified (general human communication and therapeutic contexts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:01.985429+00:00"}
{"study_id": 22304, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to enhance nurses' knowledge and understanding of laughter therapy, its components, and its physical and psychosocial benefits.", "results_summary": "The article discusses the evolution and practice of laughter therapy, highlighting its physical and psychosocial benefits for both patients and nurses. It describes how laughter therapy can enhance well-being through physical exercise, relaxation techniques, and simulated vigorous laughter.", "population_specificity": "Nurses and patients engaging in laughter therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:02.421017+00:00"}
{"study_id": 22305, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of laughter as a non-invasive method to terminate supraventricular tachycardia (SVT) in pediatric patients, comparing its effects to traditional vagal maneuvers.", "results_summary": "The study found that laughter induced by a humorous stimulus (an inflated examination glove shaped like an elephant) successfully terminated an episode of SVT in a 10-year-old girl after traditional vagal maneuvers failed. The case suggests laughter may share physiological mechanisms with the Valsalva maneuver, warranting further investigation.", "population_specificity": "A 10-year-old girl presenting with SVT in a metropolitan emergency department.", "effective_dosage": "Not specified (single spontaneous laughter episode).", "study_duration": "Immediate (laughter terminated SVT during the episode).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:05.163297+00:00"}
{"study_id": 22309, "supplement_id": 1278, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To quantify the effect of laughter and humour interventions on depression, anxiety, and sleep quality in adults.", "results_summary": "Meta-analysis showed that laughter and humour interventions significantly decreased depression and anxiety and improved sleep quality in adults, with long-term interventions being more effective for depression.", "population_specificity": "Adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:06.645427+00:00"}
{"study_id": 22306, "supplement_id": 1278, "safety_score": "90", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of laughter therapy on health-related quality of life (QOL) in cancer patients as an exploratory endpoint.", "results_summary": "The study found that laughter therapy significantly improved cognitive function and reduced pain in cancer patients for a short period, though other QOL domains showed no significant differences. The intervention group reported better outcomes compared to the control group.", "population_specificity": "Cancer patients aged 40-64 years in Japan.", "effective_dosage": "One laughter therapy session every two weeks for seven weeks (total of four sessions).", "study_duration": "Seven weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:06.865606+00:00"}
{"study_id": 22307, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 55, "study_goal": "The researchers aimed to broadly describe the field of laughter-inducing therapies and estimate their effects on mental and physical health across diverse populations and conditions.", "results_summary": "The study found that 'simulated' (non-humorous) laughter is more effective than 'spontaneous' (humorous) laughter, and laughter-inducing therapies can improve depression, though overall study quality was low with substantial risk of bias.", "population_specificity": "People of any age, healthy or with a mental or physical condition.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:07.740346+00:00"}
{"study_id": 22310, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to investigate the feasibility and potential efficacy of Laughter Yoga (LY) for improving residual mood, anxiety, and stress symptoms in adults diagnosed with depression.", "results_summary": "The LY group showed statistically greater decreases in depression and improvements in mental health-related quality of life compared to the control group immediately post-intervention. Participants reported high satisfaction with the intervention, though qualitative feedback suggested some aspects required modification.", "population_specificity": "Working-aged adults with a clinical diagnosis of depression.", "effective_dosage": "Eight sessions over four weeks.", "study_duration": "Four weeks (with follow-up at three months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:08.827998+00:00"}
{"study_id": 22311, "supplement_id": 1278, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether hearing laughter could reduce stress and improve autonomic nervous system recovery after a stress-loading task.", "results_summary": "Hearing laughter significantly increased parasympathetic nervous activity (measured by lnHF) compared to rest, suggesting a relaxing effect. Subjective stress decreased in both groups, but laughter had a unique physiological benefit.", "population_specificity": "90 healthy students", "effective_dosage": "5 minutes of listening to a laughter CD", "study_duration": "5 minutes", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:09.036454+00:00"}
{"study_id": 22313, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate the association between gelastic seizures (uncontrolled laughter) and cognitive/behavioral impairments, particularly in patients with hypothalamic hamartomas or other brain lesions.", "results_summary": "The study found that gelastic seizures, often linked to hypothalamic hamartomas or frontotemporal lesions, are associated with progressive cognitive decline and behavioral issues. Early diagnosis via neuroimaging and EEG is critical to avoid unnecessary treatments, though the condition may be pharmacoresistant and require surgical intervention.", "population_specificity": "A 40-year-old man with a history of brain tumor, diabetes mellitus, schizophrenia, and long-standing gelastic seizures since childhood.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:11.222845+00:00"}
{"study_id": 22314, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to highlight that pathological laughter can be an atypical initial symptom of stroke, potentially leading to misdiagnosis.", "results_summary": "The study described a case where pathological laughter preceded left hemiparesis in a stroke patient, leading to delayed diagnosis and treatment due to atypical presentation. Emergency physicians should recognize such behavioral changes as potential stroke indicators.", "population_specificity": "A 57-year-old patient presenting with sudden left hemiparesis and pathological laughter.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:12.986691+00:00"}
{"study_id": 22316, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to critically evaluate the effects of group-based Laughter Yoga on improving mental health in adults.", "results_summary": "Laughter Yoga showed short-term improvement in depressive symptoms in two studies, but overall evidence was weak due to poor study quality and inconsistent results. There was insufficient evidence to support its effectiveness compared to other group-based interventions.", "population_specificity": "Adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:13.794045+00:00"}
{"study_id": 22315, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether laughter yoga (simulated laughter) and spontaneous laughter (watching a comedy movie) affect cortisol and DHEA levels and cortisol/DHEA ratios.", "results_summary": "Laughter yoga and spontaneous laughter significantly decreased cortisol levels and cortisol/DHEA ratios, with spontaneous laughter having a longer-lasting effect. DHEA levels remained unchanged in the laughter yoga group.", "population_specificity": "120 healthy university students", "effective_dosage": "Not specified", "study_duration": "Single session (measurements taken immediately before, immediately after, and 30 minutes after the intervention)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:15.157634+00:00"}
{"study_id": 22317, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the preliminary effect of laughter therapy on loneliness and death anxiety in older adults living in nursing homes.", "results_summary": "Laughter therapy significantly reduced loneliness scores (emotional and social subscales) and decreased death anxiety related to exposure, but had no significant effect on overall death anxiety, death uncertainty, or pain subscales.", "population_specificity": "Older adults living in nursing homes in Turkey.", "effective_dosage": "Twice a week.", "study_duration": "5 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:15.286014+00:00"}
{"study_id": 22318, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to examine the effects of laughter therapy on perceived stress and psycho-neuro-endocrine-immune responses in obese women.", "results_summary": "The laughter therapy program significantly reduced perceived stress, psychological stress response, fasting blood sugar, interleukin-6, and tumor necrosis factor alpha, but had no significant effect on heart rate variability measures or cortisol levels.", "population_specificity": "Obese women aged 30-50 years with a BMI over 25 kg/m\u00b2 (pre-menopausal).", "effective_dosage": "12 sessions over 6 weeks (frequency not specified).", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:16.819953+00:00"}
{"study_id": 22319, "supplement_id": 1278, "safety_score": "30", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate the anatomical and stimulation-related mechanisms behind uncontrollable laughter induced by subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson's disease patients.", "results_summary": "Unilateral STN-DBS induced uncontrollable laughter when activating ventral, medial, and inferior contacts, with electrode placement varying between patients. The findings suggest stimulation of ventral/medial STN or adjacent limbic structures/SNr as the likely cause of this behavioral change.", "population_specificity": "Two Parkinson's disease patients experiencing uncontrollable laughter post-STN-DBS surgery.", "effective_dosage": "Not specified (stimulation parameters varied by patient).", "study_duration": "Not specified (acute effects observed during programming sessions).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:18.290245+00:00"}
{"study_id": 22320, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to assess the potential of laughter and humor interventions to enhance well-being in adults aged 60+ and to develop a classification system for comparing different intervention types.", "results_summary": "Well-being measures showed at least one significant positive effect in all interventions, but confounding factors were present, and individual laughter was not measured. The study concluded that isolating and tracking laughter parameters is needed for stronger evidence.", "population_specificity": "Adults aged 60 and older.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:19.159372+00:00"}
{"study_id": 22321, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the therapeutic benefits of humor, laughter, and clown interventions on the physical and psychological health of elderly individuals.", "results_summary": "The abstract indicates a literature review was conducted, suggesting potential benefits of laughter and humor-based interventions for elderly health, though specific outcomes are not detailed.", "population_specificity": "Elderly individuals (geriatric community).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:19.692032+00:00"}
{"study_id": 22322, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to explore the effects of laughter therapy on reducing stress and emotional exhaustion among community care workers supporting HIV-affected families.", "results_summary": "Participants reported improved positive emotions, coping, interpersonal relationships, and care work after laughter therapy. Quantitative results confirmed reductions in stress, anxiety, and depression.", "population_specificity": "Volunteer community care workers supporting HIV/AIDS-affected orphans and vulnerable children in Soweto, South Africa.", "effective_dosage": "Daily laughter therapy sessions (specific duration per session not mentioned).", "study_duration": "One month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:22.076133+00:00"}
{"study_id": 22324, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of a laughter yoga program on mood and physiological measures (blood pressure and pulse) in older adults living in residential aged care homes.", "results_summary": "The study found that laughter yoga significantly improved positive mood and happiness while reducing negative mood in weeks 3 and 6. It also significantly lowered systolic blood pressure in weeks 1 and 6.", "population_specificity": "Older adults (28 residents) living in residential aged care homes.", "effective_dosage": "Not specified (6-week program, frequency not detailed).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:23.660176+00:00"}
{"study_id": 22323, "supplement_id": 1278, "safety_score": "95", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to explore the biochemical, physiological, and immunological mechanisms by which laughter therapy influences wellbeing and disease prognosis, particularly in type 2 diabetes mellitus (T2DM) and its cardiovascular complications.", "results_summary": "Laughter therapy was found to delay the onset of diabetic complications, enhance cardiovascular functions, and rectify homeostatic abnormalities in T2DM. It modulates hormonal and immunological parameters, improving disease outcomes.", "population_specificity": "Individuals with type 2 diabetes mellitus (T2DM) and potential cardiovascular complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:24.187877+00:00"}
{"study_id": 22325, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effect of laughter therapy on the quality of life of nursing home residents.", "results_summary": "Laughter therapy significantly improved general and subscale quality-of-life scores (e.g., physical functioning, vitality, social functioning) in the experimental group compared to pretest measurements. The study concluded that laughter therapy should be integrated into routine nursing interventions for nursing home residents.", "population_specificity": "Nursing home residents in Turkey (32 in the experimental group, 33 in the control group).", "effective_dosage": "21 sessions, administered two days per week.", "study_duration": "Approximately 12 weeks (2 March - 25 May 2015).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:25.481205+00:00"}
{"study_id": 22326, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the feasibility and potential benefits of a novel improvisation theater program for improving quality of life in Parkinson's disease patients.", "results_summary": "The study found high attendance (95%) and participant satisfaction, with significant improvement in activities of daily living (UPDRS part II). Participants reported enjoyment and perceived benefits for their symptoms.", "population_specificity": "Patients with Parkinson's disease of varying ages and disease severity.", "effective_dosage": "60-minute weekly sessions for 12 weeks.", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:25.667275+00:00"}
{"study_id": 22328, "supplement_id": 1278, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of laughter therapy as a non-pharmacological treatment for improving mental health and mitigating stress.", "results_summary": "Laughter therapy was found to positively impact mental health, reduce stress-related hormones, and improve neurotransmitter activity, suggesting benefits for stress and depression. It is accessible, noninvasive, and shows potential as an adjuvant therapy.", "population_specificity": "General population experiencing stress or depression (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:27.142063+00:00"}
{"study_id": 22327, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether combining simulated laughter with a moderate-intensity physical activity program (LaughActive) could increase participation, health, and self-efficacy for physical activity among older adults in assisted living facilities.", "results_summary": "The study found significant improvements in mental health, aerobic endurance, and self-efficacy for exercise among participants who engaged in the LaughActive program. These results suggest that laughter-enhanced physical activity may benefit older adults' health and adherence to exercise.", "population_specificity": "Older adults residing in 4 assisted living facilities (n = 27).", "effective_dosage": "Twice-weekly LaughActive classes.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:27.496284+00:00"}
{"study_id": 22329, "supplement_id": 1278, "safety_score": "95", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to review the current medical understanding of laughter's physiological effects and recommend how physicians might harness its benefits for patients.", "results_summary": "The study found that laughter has significant psychological benefits and emerging evidence of positive physiological effects, suggesting it could be prescribed as a natural, free, and easily distributable modality for patient care.", "population_specificity": "Not specified (general discussion of laughter's effects)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:29.565854+00:00"}
{"study_id": 22312, "supplement_id": 1278, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to investigate the effects of laughter therapy on physiological and psychological function in older people.", "results_summary": "Laughter therapy significantly reduced systolic blood pressure and heart rate, increased plasma serotonin, decreased salivary chromogranin A, and improved depression, sociability, and activity levels in older adults.", "population_specificity": "Older people who regularly attended an elderly day care center (n=17).", "effective_dosage": "Stand-up comedy as laughter therapy once a week.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:29.778228+00:00"}
{"study_id": 22331, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine the impact of Laughter Yoga on well-being in adults with Parkinson\u2019s disease and their caregivers.", "results_summary": "The study found statistically significant improvements in well-being measures (e.g., mood, stress, relaxation) for both adults with Parkinson\u2019s disease and their caregivers after a single Laughter Yoga session.", "population_specificity": "Adults diagnosed with Parkinson\u2019s disease (n=47) and their caregivers (n=38).", "effective_dosage": "One 45-minute Laughter Yoga session.", "study_duration": "Single session (45 minutes).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:32.567905+00:00"}
{"study_id": 192814, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on laughter as a supplement or intervention but describes it as a behavioral characteristic of Angelman Syndrome.", "results_summary": "The study does not evaluate laughter's effects but mentions frequent laughter as a unique behavior in Angelman Syndrome patients.", "population_specificity": "Patients with Angelman Syndrome (AS).", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:32.574731+00:00"}
{"study_id": 22332, "supplement_id": 1278, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the impact of clown doctors' home visits using joy, humor, and laughter on enhancing humanized care and problem-solving in socially vulnerable families.", "results_summary": "The study found that clown doctors' interventions strengthened bonds with families, improved humanized care, and facilitated reflections on daily problems, leading to potential solutions for everyday difficulties.", "population_specificity": "Socially vulnerable families in micro areas served by two family health teams.", "effective_dosage": "Not specified", "study_duration": "8 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:32.737295+00:00"}
{"study_id": 22817, "supplement_id": 1279, "safety_score": "90", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the feasibility, psychological and physiological impact of Laughter Yoga in end-stage kidney disease patients undergoing hemodialysis, and estimate sample sizes for future studies.", "results_summary": "Laughter Yoga showed non-significant improvements in happiness, mood, and optimism, with reduced stress and fewer intradialytic hypotensive episodes, but no changes in lung function or blood pressure. Nurses reported positive perceptions of the intervention.", "population_specificity": "End-stage kidney disease patients receiving hemodialysis.", "effective_dosage": "30-minute sessions, three times per week.", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:33.873202+00:00"}
{"study_id": 22818, "supplement_id": 1279, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether laughter yoga could reduce stress in cancer patients before chemotherapy.", "results_summary": "The study found a statistically significant reduction in stress levels (p<0.05) in the test group after laughter yoga intervention compared to the control group.", "population_specificity": "37 hospitalized cancer patients at Shohada Tajrish Hospital (Behnam Daneshpoor Charity Organization).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:34.703363+00:00"}
{"study_id": 22819, "supplement_id": 1279, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to determine the effect of laughter Yoga on general health among nursing students, specifically focusing on physical and sleep disorders, anxiety, depression, and social function.", "results_summary": "The study found that laughter Yoga significantly improved general health in nursing students, reducing physical and sleep disorders, lowering anxiety and depression, and enhancing social function compared to the control group.", "population_specificity": "38 male nursing students from Isfahan University of Medical Sciences.", "effective_dosage": "Eight 1-hour sessions (two sessions per week).", "study_duration": "4 weeks (two sessions per week).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:35.826275+00:00"}
{"study_id": 22821, "supplement_id": 1279, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effectiveness of Laughter Yoga and group exercise therapy in reducing depression and increasing life satisfaction in elderly depressed women.", "results_summary": "Laughter Yoga significantly reduced depression scores and increased life satisfaction compared to the control group, with effects comparable to exercise therapy. No significant difference was found between Laughter Yoga and exercise therapy groups for depression, but Laughter Yoga showed superior life satisfaction improvement over the control.", "population_specificity": "Elderly depressed women (aged 60+) from a cultural community in Tehran, Iran.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:38.851839+00:00"}
{"study_id": 22820, "supplement_id": 1279, "safety_score": "90", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the clinical utility of laughter yoga in improving psychological and physiological measures in outpatients awaiting organ transplantation.", "results_summary": "Participants showed improved immediate mood (vigor-activity and friendliness) and increased HRV after laughter yoga. Both laughter and control interventions appeared to improve longer-term anxiety, but the study lacked statistical analysis due to low enrollment.", "population_specificity": "Patients awaiting organ transplantation (three heart and three lung), aged 51-69, without major recent surgery, hernia, uncontrolled hypertension, or severe heart failure.", "effective_dosage": "20-minute sessions, 10 sessions over 4 weeks.", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:39.474442+00:00"}
{"study_id": 72155, "supplement_id": 1279, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to highlight the positive effects of humor, including Laughter Yoga, on stress reduction and therapeutic alliance in clinical settings.", "results_summary": "The study suggests that humor, including playful therapy, attenuates stress indices and improves therapeutic relationships, with theoretical support from Freudian, rational emotive therapy, and kleinian perspectives.", "population_specificity": "Patients and clinicians in daily life (not further specified).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:40.494909+00:00"}
{"study_id": 72156, "supplement_id": 1279, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review evidence on laughter and humor therapy, including Laughter Yoga, for potential physiological and psychological benefits in dialysis patients.", "results_summary": "The abstract suggests laughter and humor therapy may improve depression, anxiety, pain, immunity, fatigue, sleep quality, respiratory function, and blood glucose, but notes the need for further research in dialysis populations.", "population_specificity": "Primarily dialysis patients, with additional evidence from children, the elderly, and individuals with mental health, cancer, and chronic conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:40.604886+00:00"}
{"study_id": 22035, "supplement_id": 1280, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether lavender oil inhalation could reduce pre-endoscopy anxiety in children.", "results_summary": "Lavender oil inhalation significantly reduced state anxiety scores in children before endoscopy, though no significant difference was found in trait anxiety scores. The intervention group showed statistically lower state anxiety compared to placebo and control groups.", "population_specificity": "Children aged 9-12 years undergoing endoscopy in a tertiary center.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:41.483485+00:00"}
{"study_id": 22034, "supplement_id": 1280, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the pharmacokinetics and antitumor properties of a nanostructured lipid carrier (NLC) formulation containing lavender oil and bupivacaine, comparing it to a synthetic lipid control.", "results_summary": "The study found that lavender oil in the NLC formulation did not exhibit synergistic antitumor effects with bupivacaine but contributed to sustained drug release and improved local antitumor therapy. Both NLC formulations (with and without lavender oil) significantly inhibited tumor growth (70% and 72%, respectively) compared to free bupivacaine (17%).", "population_specificity": "Animal models (specific species not mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:41.635148+00:00"}
{"study_id": 22037, "supplement_id": 1280, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical efficacy of lavender oil with Piroxicam gel (PG) for treating knee osteoarthritis (OA) in terms of pain severity and physical function.", "results_summary": "Lavender oil significantly reduced VAS pain scores from 5.37 to 3.00 after one month, with effects comparable to PG. No significant difference was found between the two treatments, suggesting lavender oil is an effective natural alternative for knee OA.", "population_specificity": "90 patients with knee osteoarthritis.", "effective_dosage": "Not specified.", "study_duration": "Two months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:43.158942+00:00"}
{"study_id": 22038, "supplement_id": 1280, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effectiveness of inhaled lavender aromatherapy in reducing postoperative pain and analgesic consumption in adults.", "results_summary": "Inhaled lavender aromatherapy significantly reduced postoperative pain, but evidence was insufficient to confirm its effect on reducing analgesic consumption. Mixed results were observed regarding analgesic use, with some studies reporting reduced consumption and others finding no notable effect.", "population_specificity": "Adults who underwent cardiac or abdominal surgery.", "effective_dosage": "Not specified", "study_duration": "Pain levels were assessed at 5, 30, and 60 minutes after intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:43.580713+00:00"}
{"study_id": 22040, "supplement_id": 1280, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether oral administration of lavender extract could reduce dental anxiety scores in patients requiring endodontic treatment.", "results_summary": "The study found that patients who received lavender extract experienced a significantly greater reduction in dental anxiety scores compared to the control group (p=0.001), with the effect persisting across different demographic groups.", "population_specificity": "64 patients with symptomatic irreversible pulpitis requiring endodontic treatment.", "effective_dosage": "20 drops of lavender extract in 250 ml of water, administered once.", "study_duration": "Single administration, effects measured 60 minutes after ingestion.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:46.923277+00:00"}
{"study_id": 22041, "supplement_id": 1280, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the short- and long-term impacts of lavender aromatherapy alone versus combined with music therapy on nurses' physical and psychological well-being during the COVID-19 pandemic.", "results_summary": "Lavender aromatherapy significantly reduced physiological and psychological stress measures in nurses, with even greater improvements when combined with music therapy, showing both immediate and lasting effects over six weeks.", "population_specificity": "60 nurses from a regional teaching hospital in central Taiwan.", "effective_dosage": "Inhaling gas infused with lavender essential oil once a week for 20 minutes.", "study_duration": "Six weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:47.407810+00:00"}
{"study_id": 22044, "supplement_id": 1280, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the therapeutic effects of lavender oil in a rat model of type 1 diabetes mellitus with thrombosis, focusing on its antioxidant, anti-inflammatory, hypoglycemic, and organ-protective properties.", "results_summary": "Lavender oil demonstrated dose-dependent benefits, including reduced proinflammatory cytokines, oxidative stress, improved glycemic control, and antithrombotic effects, with the 200 mg/kg bw dose showing significant efficacy.", "population_specificity": "Male Wistar rats with streptozotocin-induced type 1 diabetes mellitus and experimentally induced thrombosis.", "effective_dosage": "100 and 200 mg/kg body weight.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:48.808664+00:00"}
{"study_id": 22046, "supplement_id": 1280, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine how combining lavender oil inhalation with cold foot baths affects autonomic variability in healthy individuals.", "results_summary": "The study found that the combination significantly modulated autonomic activity, improving vagal balance and reducing blood pressure, with notable differences in heart rate variability and blood pressure between groups.", "population_specificity": "60 healthy individuals", "effective_dosage": "Not specified", "study_duration": "20-minute intervention", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:49.423284+00:00"}
{"study_id": 22042, "supplement_id": 1280, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the acceptability, feasibility, effectiveness, and cost-effectiveness of a Code Lavender protocol utilizing chaplain support and stress-relief items for mitigating healthcare worker distress.", "results_summary": "The study found the Code Lavender protocol to be acceptable, feasible, effective, and cost-effective in mitigating distress among healthcare workers. The protocol leveraged chaplain support and stress-relief items to provide simple, on-demand support.", "population_specificity": "Healthcare workers", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:49.920633+00:00"}
{"study_id": 24386, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine the effects of LSD on creativity using multimodal tasks and multidimensional approaches to address previous methodological shortcomings.", "results_summary": "LSD increased novelty, surprise, originality, and semantic distances (\"pattern break\"), decreased utility and convergent thinking (\"disorganization\"), and enhanced symbolic thinking and ambiguity (\"meaning\"). These changes suggest LSD shifts cognitive resources toward novel and symbolic thinking.", "population_specificity": "24 healthy volunteers", "effective_dosage": "50 \u03bcg of LSD", "study_duration": "Single administration (near drug peak)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:56.834381+00:00"}
{"study_id": 24385, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the sub-acute effects of LSD on cognitive functions, including memory, verbal fluency, and cognitive flexibility, 24 hours after dosing.", "results_summary": "LSD improved visuospatial memory and phonological verbal fluency but impaired cognitive flexibility compared to placebo. The study suggests potential therapeutic applications for conditions involving memory and language declines.", "population_specificity": "24 healthy volunteers", "effective_dosage": "50 \u03bcg LSD (single dose)", "study_duration": "24 hours post-dosing", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:57.317090+00:00"}
{"study_id": 24382, "supplement_id": 1303, "safety_score": "85", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the safety and efficacy of LSD in a psychedelic-assisted group therapy model for patients with chronic complex post-traumatic stress disorder (c-PTSD) and related conditions.", "results_summary": "The majority of participants showed clinical improvement, with LSD used to deepen therapeutic effects after initial MDMA-assisted therapy. No serious adverse events were reported.", "population_specificity": "Patients with chronic complex PTSD, dissociative disorders, and other post-traumatic conditions.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:57.319286+00:00"}
{"study_id": 24380, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether LSD could enhance cognition by leveraging its effects on neural plasticity, particularly through the mTOR pathway.", "results_summary": "LSD improved performance in novel object recognition tasks in rats and visuo-spatial memory tasks in humans, with proteomic analysis linking these effects to metabolic pathways associated with neural plasticity, including mTOR. A neural network model supported these findings by simulating LSD-induced cognitive gains based on plasticity strength.", "population_specificity": "Rats and humans (specific demographics not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:57.456960+00:00"}
{"study_id": 24383, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to test the hypothesis that LSD reduces whole-brain hierarchical organization, a proposed key mechanism underlying the psychedelic state, using neuroimaging techniques.", "results_summary": "The study found that LSD significantly flattened the principal gradient of cortical connectivity, reducing functional differentiation between unimodal and transmodal cortex, and increased unimodal-transmodal crosstalk, supporting the proposed mechanistic model of the psychedelic state.", "population_specificity": "Small sample sizes (N=15 for LSD dataset).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:57.934717+00:00"}
{"study_id": 24379, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effects of repeated LSD administration on DNA methylation and protein expression in the mouse prefrontal cortex to understand its therapeutic mechanisms.", "results_summary": "LSD significantly altered DNA methylation at 635 CpG sites and affected the expression of 178 proteins, influencing pathways related to nervous system development, synaptic plasticity, and neuron viability. Four genes (Coro7, Pef1, Rps24, Abhd6) showed differential methylation and increased expression, suggesting LSD's role in neuroplasticity.", "population_specificity": "Mice (prefrontal cortex tissue analysis)", "effective_dosage": "30 \u03bcg/kg/day", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:58.034478+00:00"}
{"study_id": 24381, "supplement_id": 1303, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the incidence and nature of LSD-related adverse experiences leading to emergency medical treatment in an international sample of past-year LSD users.", "results_summary": "Out of 10,293 past-year LSD users, 1.0% sought emergency medical treatment, with psychological symptoms (e.g., anxiety, panic) being most common. Adverse reactions were typically short-lived, with poor \"setting\" and \"mindset\" cited as common contributory factors.", "population_specificity": "International sample of past-year LSD users (n=10,293) from the 2017 Global Drug Survey.", "effective_dosage": "Not specified", "study_duration": "Not specified (retrospective 12-month incidence study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:58.651942+00:00"}
{"study_id": 24384, "supplement_id": 1303, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, tolerability, pharmacokinetics, and subjective effects of LSD (50, 75, and 100 \u00b5g doses) in healthy adults within a novel intervention paradigm.", "results_summary": "The study found that LSD was well-tolerated with no serious adverse events, only mild to moderate expected adverse effects, and induced greater subjective effects compared to placebo. Maximum plasma levels occurred within 1.2\u20132 hours post-administration, with an apparent half-life of 2.8\u20134.3 hours.", "population_specificity": "Healthy adults (mean age = 28.8 years).", "effective_dosage": "50 \u00b5g, 75 \u00b5g, 100 \u00b5g LSD, or placebo followed by 75 \u00b5g LSD, administered once or twice (1 week apart).", "study_duration": "Single-day administration with follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:25:59.154416+00:00"}
{"study_id": 24387, "supplement_id": 1303, "safety_score": "30", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the toxic effects of LSD and PCP on human neuroblastoma SH-SY5Y cells, focusing on DNA damage and oxidative stress-related effects.", "results_summary": "LSD at 6.25 \u03bcmol/L significantly increased primary DNA damage, oxidative stress markers (malondialdehyde, ROS, GSH), and antioxidant enzyme activities compared to control, indicating greater DNA damaging potential and oxidative activity than PCP.", "population_specificity": "Human neuroblastoma SH-SY5Y cell line.", "effective_dosage": "6.25 \u03bcmol/L LSD.", "study_duration": "24-hour exposure.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:04.905094+00:00"}
{"study_id": 24388, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how LSD affects the stream of thought, specifically examining mind-wandering and free association.", "results_summary": "LSD induced distinct facets of mind-wandering (\"chaos,\" \"meaning,\" \"sensation\") and increased abstract flow in free association, with effects peaking between +2 h and +6 h post-administration. The study identified a potential therapeutic window at +4 h for psycholytic therapy.", "population_specificity": "24 healthy participants", "effective_dosage": "50 \u03bcg LSD (single dose)", "study_duration": "Assessments conducted up to +24 h post-administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:05.473004+00:00"}
{"study_id": 24391, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the paradoxical relationship between LSD-induced psychotic experiences and its therapeutic potential by examining key parameters like aberrant salience, suggestibility, and mindfulness.", "results_summary": "LSD induced psychedelic experiences (altered consciousness, mystical experiences, ego-dissolution) and increased aberrant salience and suggestibility but not mindfulness. Aberrant salience correlated with complex imagery, mystical experiences, and ego-dissolution, while suggestibility showed no correlations with other effects.", "population_specificity": "24 healthy volunteers", "effective_dosage": "50 \u03bcg LSD (single dose)", "study_duration": "Single administration (crossover design)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:05.829820+00:00"}
{"study_id": 24390, "supplement_id": 1303, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the acute safety and subjective effects of LSD in healthy subjects across different dosages in a controlled setting.", "results_summary": "LSD dose-dependently increased positive subjective effects (e.g., good drug effects) more than negative effects (e.g., bad drug effects, anxiety), with moderate physiological changes (e.g., heart rate, blood pressure). No severe adverse effects or organ toxicity were observed, though transient flashbacks were reported in six subjects.", "population_specificity": "83 healthy subjects", "effective_dosage": "Single doses of 25, 50, 100, and 200 \u00b5g LSD base", "study_duration": "Acute effects monitored over 12 hours, subacute effects over 24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:06.011821+00:00"}
{"study_id": 24389, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the effects of LSD on EEG activity in freely moving rats to evaluate its translational validity compared to human studies.", "results_summary": "LSD induced a global decrease/desynchronization of EEG activity and disconnection within 1-40 Hz, with major changes localized in the frontal and sensorimotor cortex. A rebound of occipital theta activity was detected at later stages.", "population_specificity": "Freely moving rats", "effective_dosage": "0.2 mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:06.104225+00:00"}
{"study_id": 24392, "supplement_id": 1303, "safety_score": "30", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore whether long-lasting personality changes, particularly \"connectedness,\" occurred in psychiatric patients treated with LSD from 1960 to 1974.", "results_summary": "The study found no evidence of \"connectedness\" but observed other lasting personality changes in 2-4 patients, with persistent unwanted effects in many. Side effects like suicide attempts, suicides, and one homicide were noted but underreported in historical analyses.", "population_specificity": "151 Danish psychiatric patients treated with LSD from 1960 to 1974.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:06.156301+00:00"}
{"study_id": 24393, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the therapeutic effects of LSD in psychiatric clinical settings, particularly for patients with alcoholism.", "results_summary": "The study reported benefits of LSD therapy for patients with alcoholism and highlighted the enriching experience for nurses guiding patients through treatment. The nurse's role was described as vital, with LSD therapy being highly welcomed on the psychiatric unit.", "population_specificity": "Patients with alcoholism and psychiatric conditions (e.g., manic-depressive psychosis).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:07.014625+00:00"}
{"study_id": 24394, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to rigorously examine the cognitive, emotional, and neurobiological effects of microdosing LSD compared to placebo in healthy males.", "results_summary": "The abstract does not report results, as it describes a planned study rather than completed findings.", "population_specificity": "80 healthy male participants", "effective_dosage": "10 \u03bcg every 3rd day", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:07.049500+00:00"}
{"study_id": 24395, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze trends and correlates of LSD use from 2002-2018 and develop a typology of use and misuse.", "results_summary": "LSD use increased by 200% over the study period, with higher prevalence among well-educated individuals, unmarried individuals, those with antisocial behavior, and those with comorbid mental health and substance abuse disorders. Four distinct subclasses of LSD users were identified, two of which involved severe mental health disturbances and criminal justice involvement.", "population_specificity": "Participants from the National Survey on Drug Use and Health (NSDUH) between 2002-2018.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:13.033064+00:00"}
{"study_id": 24399, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential therapeutic properties of LSD and other hallucinogens in treating psychiatric disorders, focusing on their pharmacology and behavioral effects.", "results_summary": "The study highlights emerging evidence supporting LSD's potential therapeutic benefits, particularly in modulating functional brain connectivity and treating mental diseases, alongside other hallucinogens like psilocybin and MDMA.", "population_specificity": "Not specified (review of preclinical and clinical studies involving animals and humans).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:13.637952+00:00"}
{"study_id": 24402, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine the efficacy of LSD, among other substances, for treating PTSD in adults.", "results_summary": "The study did not include any trials on LSD that met the inclusion criteria, so no results regarding LSD's effects were reported.", "population_specificity": "Adults with PTSD (though no LSD-specific trials were included).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:14.332833+00:00"}
{"study_id": 24398, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the mechanism by which LSD enhances social behavior, focusing on its effects on glutamatergic neurotransmission in the medial prefrontal cortex (mPFC) and the role of mTORC1 signaling.", "results_summary": "Acute LSD did not increase social behavior, but repeated administration promoted it without antidepressant/anxiolytic effects. LSD enhanced AMPA and 5-HT2A synaptic responses in the mPFC, dependent on mTORC1 in excitatory neurons, while GABAergic neuron inhibition did not block its prosocial effects.", "population_specificity": "Male mice", "effective_dosage": "30 \u03bcg/kg, once daily", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:14.642415+00:00"}
{"study_id": 24396, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to describe patient characteristics, treatment indications, and acute psychological effects of LSD and MDMA in a Swiss compassionate use program.", "results_summary": "LSD induced pronounced alterations of consciousness and mystical-type experiences, with effects comparable to those in healthy volunteers and clinical trial patients. The study found LSD was used primarily for PTSD and depression in group settings, with sessions conducted every 3.5 months.", "population_specificity": "18 patients (12 women, 6 men) aged 29-77 with conditions like PTSD and major depression.", "effective_dosage": "100-200 \u00b5g LSD per session.", "study_duration": "Sessions occurred every 3.5 months after 3-10 psychotherapy sessions (2014-2018).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:14.693219+00:00"}
{"study_id": 24397, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess LSD's effects on the autonomic nervous system (ANS) via heart rate variability (HRV) measures and its correlation with subjective drug-induced experiences.", "results_summary": "LSD increased sympathetic activity, while ketanserin counteracted this effect by increasing parasympathetic tone. Sympathetic activity correlated positively, and parasympathetic activity negatively, with psychedelic effects, suggesting ANS activity may predict LSD's subjective experiences.", "population_specificity": "Not specified (likely healthy adults, given the crossover trial design).", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "Ketanserin (serotonin 2A receptor antagonist) was noted to counteract LSD's ANS effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:14.704949+00:00"}
{"study_id": 24403, "supplement_id": 1303, "safety_score": "50", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to discuss contemporary LSD research in the context of earlier studies, focusing on its therapeutic use and societal reactions.", "results_summary": "LSD has been used therapeutically since 1947 for conditions like anxiety, depression, and addiction, but concerns arose in the 1960s due to risks of psychosis and non-medical use. The study notes a lack of consolidated evidence for either positive or negative outcomes of LSD therapy.", "population_specificity": "Not specified (general psychiatric use).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:15.276921+00:00"}
{"study_id": 24406, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify controlled and randomized clinical trials assessing LSD's therapeutic potential in psychiatry, particularly for conditions like anxiety, depression, and alcoholism.", "results_summary": "Positive results were observed, with LSD showing therapeutic potential, especially in reducing alcoholism symptoms. Short-term changes were significant, though long-term effects showed homogenization between treatment and control groups.", "population_specificity": "567 patients with various psychiatric disorders, including alcoholism.", "effective_dosage": "20 to 800 mcg.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:21.245391+00:00"}
{"study_id": 24405, "supplement_id": 1303, "safety_score": "75", "efficacy_score": 80, "quality_score": 40, "study_goal": "The researchers aimed to document the medical consequences and potential positive effects of accidental LSD overdoses in three individuals.", "results_summary": "The study found that LSD overdoses led to sustained improvements in mood symptoms, no negative effects on pregnancy or fetal development, and positive effects on pain and morphine withdrawal symptoms.", "population_specificity": "Three individuals with accidental LSD overdoses (one with mood symptoms, one pregnant, one with pain and morphine withdrawal).", "effective_dosage": "One case involved 550 times the normal recreational dosage (exact amount not specified).", "study_duration": "Follow-up ranged from immediate effects to nearly 20 years in one case.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:21.647599+00:00"}
{"study_id": 24404, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether psilocybin/LSD could reduce relapse-like drinking in an alcohol deprivation effect (ADE) model for alcohol use disorder (AUD).", "results_summary": "The study found that neither high-dose psychedelics nor microdosing had long-lasting effects on relapse behavior in rats; only sub-chronic psilocybin treatment produced a short-term anti-relapse effect, which was deemed non-translatable to clinical settings.", "population_specificity": "Male and female rats in an ADE model.", "effective_dosage": "High dosage regime comparable to clinical studies and chronic microdosing scheme (specific amounts not detailed).", "study_duration": "Not explicitly stated, but includes sub-chronic, chronic, and single high-dose treatments.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:22.008239+00:00"}
{"study_id": 24409, "supplement_id": 1303, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to characterize and compare the acute autonomic, subjective, and endocrine effects of LSD, MDMA, and D-amphetamine in healthy subjects.", "results_summary": "LSD induced stronger subjective effects, including altered consciousness, emotional excitation, and cognitive impairments, compared to MDMA and D-amphetamine. It also produced greater autonomic responses like increased heart rate but had distinct psychological and mystical effects.", "population_specificity": "28 healthy subjects", "effective_dosage": "0.1 mg (single dose)", "study_duration": "Single-dose administration (acute effects measured)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:22.123285+00:00"}
{"study_id": 24410, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review recent neuroimaging findings to understand LSD's neuronal effects and its potential clinical applications.", "results_summary": "LSD administration was associated with extensive alterations in functional brain connectivity, particularly increased connectivity within the thalamocortical system, supporting models of hallucinogenic drug effects. However, the studies faced limitations, including potential neuroimaging biases.", "population_specificity": "Not specified (review of existing studies, likely involving healthy adults or patients with mental disorders).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:22.610115+00:00"}
{"study_id": 24407, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of a single low dose of LSD on resting-state functional connectivity and cerebral blood flow in healthy young adults.", "results_summary": "LSD increased amygdala connectivity with certain brain regions (e.g., right angular gyrus, right middle frontal gyrus) and decreased connectivity with others (e.g., postcentral gyrus, superior temporal gyrus). The dose had weak and variable effects on mood, but positive mood changes correlated with increased amygdala-middle frontal gyrus connectivity.", "population_specificity": "Healthy young adults (18-35 years old), 20 participants (men and women).", "effective_dosage": "13 \u03bcg (single dose).", "study_duration": "Single administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:22.794065+00:00"}
{"study_id": 24408, "supplement_id": 1303, "safety_score": "90", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of repeated low-dose LSD administration in older healthy individuals.", "results_summary": "LSD was well tolerated with no higher frequency of adverse events than placebo, and no impairment in cognition, balance, or proprioception was observed. Peak plasma levels occurred at 30 minutes for the 10 \u03bcg and 20 \u03bcg doses, while the 5 \u03bcg dose was undetectable.", "population_specificity": "Older healthy volunteers (mean age = 62.9 years)", "effective_dosage": "5 \u03bcg, 10 \u03bcg, and 20 \u03bcg LSD administered every 4 days", "study_duration": "21 days (6 doses total)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:22.918543+00:00"}
{"study_id": 24412, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to test the thalamic filter model by examining LSD-induced changes in effective connectivity within cortico-striato-thalamo-cortical (CSTC) pathways and the role of serotonin 2A receptor activation.", "results_summary": "LSD increased effective connectivity from the thalamus to the posterior cingulate cortex (dependent on serotonin 2A receptor activation) and decreased connectivity from the ventral striatum to the thalamus (independent of serotonin 2A receptor activation), supporting the CSTC model.", "population_specificity": "25 healthy participants", "effective_dosage": "Not specified", "study_duration": "Acute administration (single dose)", "interactions": "Ketanserin (a serotonin 2A receptor antagonist) was used to assess receptor-specific effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:30.334348+00:00"}
{"study_id": 24415, "supplement_id": 1303, "safety_score": "80", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to clarify the true causes of fatalities erroneously attributed to LSD toxicity and assess its safety profile.", "results_summary": "The study found that LSD is non-toxic and medically safe at standard doses (50-200\u03bcg), with fatalities linked to massive overdoses, extreme physical restraint, or substituted drugs rather than LSD itself. Adverse outcomes like psychological disturbances (\"bad trips\") were acknowledged but rare.", "population_specificity": "General public and individuals with reported adverse events (e.g., fatalities).", "effective_dosage": "Standard doses of 50-200\u03bcg mentioned.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:31.117788+00:00"}
{"study_id": 24414, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of LSD on alcohol consumption and preference in mice using a two-bottle choice paradigm.", "results_summary": "Mice treated with 50 \u03bcg/kg LSD showed a significant reduction in ethanol consumption (17.9%) and preference compared to controls, sustained over 46 days. No significant effects were observed at 25 \u03bcg/kg LSD, and no changes in total fluid intake or locomotor activity were noted.", "population_specificity": "Adult male C57BL/6J mice with developed ethanol preference.", "effective_dosage": "Single intraperitoneal injection of 25 or 50 \u03bcg/kg LSD.", "study_duration": "46 days post-administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:31.514892+00:00"}
{"study_id": 24411, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify the cytochrome P450 (CYP) isoforms involved in LSD metabolism and evaluate potential effects of enzyme polymorphisms or prescription drugs on LSD pharmacokinetics, as well as assess interactions of LSD and its metabolites with 5-HT receptors.", "results_summary": "The study found that several CYP enzymes (CYP2D6, 2E1, 3A4 for nor-LSD; CYP1A2, 2C9, 2E1, 3A4 for O-H-LSD) significantly contribute to LSD metabolism, with nor-LSD retaining pharmacological activity similar to LSD while O-H-LSD was largely inactive. Genetic polymorphisms and drug interactions could influence LSD pharmacokinetics and pharmacodynamics.", "population_specificity": "Human liver microsomes and hepatocyte-derived cells (in vitro study).", "effective_dosage": "Not specified (in vitro incubation).", "study_duration": "4 hours (incubation period).", "interactions": "Potential interactions with CYP inhibitors (e.g., rifampicin, omeprazole) and enzyme polymorphisms affecting LSD metabolism.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:31.544159+00:00"}
{"study_id": 24413, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the pharmacological properties of ECPLA, a structural analog of LSD, focusing on its interactions with the 5-HT2A receptor and comparing its effects to LSD and other lysergamides.", "results_summary": "ECPLA showed high affinity for serotonin, \u03b12-adrenoceptors, and D2-like dopamine receptors, acting as a potent 5-HT2A agonist. It induced head twitch responses in mice with ~40% of LSD's potency, while LAMPA and MIPLA showed similar or slightly lower potency.", "population_specificity": "C57BL/6J mice", "effective_dosage": "ECPLA ED50 = 317.2 nmol/kg (IP), LAMPA ED50 = 358.3 nmol/kg, MIPLA ED50 = 421.7 nmol/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:31.634484+00:00"}
{"study_id": 24417, "supplement_id": 1303, "safety_score": "50", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate LSD's safety and efficacy for psychiatric indications, including schizophrenia, model psychosis, depression, and psychotherapy adjunct.", "results_summary": "The study found that LSD research in the 1960s struggled to meet federal safety and efficacy standards, providing pilot data but often lacking rigorous compliance. Some investigators, like Kurland, adhered to regulations, while others fell short.", "population_specificity": "Psychiatric patients, including those with schizophrenia and depression, at Spring Grove State Hospital.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:31.745207+00:00"}
{"study_id": 24416, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to compare drug use patterns and psychiatric symptoms (anxiety and depression) between young Brazilian sexual minority and heterosexual users of ecstasy and LSD.", "results_summary": "The study found that sexual minority users had a 37% higher prevalence of depression symptoms compared to heterosexual users, with a statistically significant association (PR=1.79; 95%CI 1.03-3.11; p=0.037). No direct effects of LSD were reported.", "population_specificity": "Young Brazilian adults (mean age 22.9\u00b14.5 years) who used ecstasy and/or LSD in the past 90 days, including sexual minorities (28.7% gay or bisexual).", "effective_dosage": "Not specified", "study_duration": "Not specified (cross-sectional study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:32.027971+00:00"}
{"study_id": 24400, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effects of repeated, ascending doses of LSD on a patient with severe, treatment-resistant depression and complex personality disorder.", "results_summary": "The patient showed rapid and significant improvement in depressive symptoms, emotional instability, and suicidal ideations without experiencing acute subjective effects of LSD. Improvements persisted for ~7 days after each administration, resembling antidepressant effects seen with ketamine.", "population_specificity": "A 39-year-old female with severe, treatment-resistant depression and complex personality disorder.", "effective_dosage": "Repeated weekly and ascending doses (specific amounts not provided).", "study_duration": "Weekly administrations (exact total duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:35.094479+00:00"}
{"study_id": 24424, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop a standardized classification system (LSD score) for peristomal skin lesions to improve ostomy therapy.", "results_summary": "The study introduced the LSD score, which categorizes peristomal skin lesions (L), ostomy status (S), and systemic disease (D), providing a basis for a management algorithm. The score is designed to enhance consistency in describing lesions and improving therapy quality.", "population_specificity": "Patients with ostomies experiencing peristomal skin lesions.", "effective_dosage": "Not applicable", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:39.539925+00:00"}
{"study_id": 24426, "supplement_id": 1303, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of LSD and other psychedelics in treating addictions, focusing on safety, efficacy, and therapeutic mechanisms.", "results_summary": "The study found that LSD has a strong safety profile with low mortality and minimal physical dependence, and it may assist in addiction recovery through serotonin-based therapeutic mechanisms, including an \"after-glow\" effect.", "population_specificity": "Individuals with drug dependencies (specific population not detailed in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:39.602079+00:00"}
{"study_id": 24418, "supplement_id": 1303, "safety_score": "30", "efficacy_score": 40, "quality_score": 50, "study_goal": "The researchers aimed to retrospectively assess the short-term outcomes of LSD treatment in 151 Danish psychiatric patients who received economic compensation due to adverse effects.", "results_summary": "The study found mixed short-term outcomes, with 52 patients improving and 48 worsening acutely. Long-term outcomes were generally poor, and a dose-index in neurotic patients indicated a risk of acute worsening.", "population_specificity": "151 Danish psychiatric patients treated with LSD in the 1960s, including subgroups with neurosis and obsessive-compulsive neurosis.", "effective_dosage": "Not specified (dose-index used: number of treatments multiplied by maximal LSD dose).", "study_duration": "Not specified (retrospective follow-up approximately 25 years post-treatment).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:39.874877+00:00"}
{"study_id": 24419, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of the 5-HT2AR subtype and cortical midline regions in personal relevance processing by studying LSD's effects with and without ketanserin pretreatment.", "results_summary": "Ketanserin fully blocked general subjective LSD effects and inhibited LSD-induced attribution of personal relevance to meaningless stimuli. The findings highlight the critical role of 5-HT2AR and cortical midline regions in personal relevance processing.", "population_specificity": "Humans (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "Ketanserin (5-HT2AR antagonist) was used as a pretreatment to block LSD effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:40.029558+00:00"}
{"study_id": 24425, "supplement_id": 1303, "safety_score": "40", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to document a case of LSD-associated \"Alice in Wonderland Syndrome\" (AIWS) persisting after LSD cessation, known as Hallucinogen Persisting Perception Disorder (HPPD).", "results_summary": "The study reported a case of AIWS (visual illusions like macropsia and micropsia) that emerged during LSD use and persisted as HPPD after discontinuation. The condition was benign and reversible, resolving completely after one year without medical treatment.", "population_specificity": "A patient with a history of sporadic recreational use of cannabis, alcohol, and LSD.", "effective_dosage": "Not specified", "study_duration": "Not specified (follow-up period was one year)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:41.087172+00:00"}
{"study_id": 24421, "supplement_id": 1303, "safety_score": "20", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the long-term safety and adverse effects of LSD treatment in psychiatric patients.", "results_summary": "The study found severe long-term side effects in most patients, including flashbacks in two-thirds of cases, and reported incidents of homicide, suicides, and suicide attempts. Financial compensation was awarded to all applicants under the Danish LSD Damages Law due to LSD-inflicted harm.", "population_specificity": "151 psychiatric patients treated with LSD in Denmark between 1960 and 1973.", "effective_dosage": "Not specified", "study_duration": "Treatment duration not specified, but side effects persisted many years afterward.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:43.763756+00:00"}
{"study_id": 24422, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine how LSD affects behavior in mice with partial serotonin transporter (Sert) deficiency compared to wild-type mice.", "results_summary": "LSD increased serotonin-sensitive behaviors (head twitching, tremors, backwards gait) in both Sert(+/+) and Sert(+/-) mice, but Sert(+/-) mice showed longer self-grooming regardless of LSD treatment. No significant interactions between LSD and Sert gene dosage were observed.", "population_specificity": "Heterozygous Sert(+/-) mice and wild-type Sert(+/+) mice.", "effective_dosage": "0.32 mg/kg (acute administration).", "study_duration": "Single acute dose.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:44.085243+00:00"}
{"study_id": 24430, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effectiveness of enzyme replacement therapy (ERT) for adults with late-onset Pompe disease.", "results_summary": "The study found significant improvements in muscle strength and walking distance (6MWT) over the first 2 years of ERT, but no significant effects on respiratory function or BMI.", "population_specificity": "Adults with late-onset Pompe disease (N=62) attending a specialist treatment center in England.", "effective_dosage": "Not specified", "study_duration": "Up to 3.1 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:47.153701+00:00"}
{"study_id": 24428, "supplement_id": 1303, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the safety and long-term efficacy of LSD-assisted psychotherapy in reducing anxiety and improving quality of life in patients with life-threatening diseases.", "results_summary": "Participants reported sustained reductions in anxiety (77.8%) and improved quality of life (66.7%) over 12 months, with no lasting adverse reactions. Subjective experiences included emotional catharsis, confrontation of anxieties, and lasting psychological restructuring.", "population_specificity": "Patients with anxiety associated with life-threatening diseases.", "effective_dosage": "Not specified", "study_duration": "12-month follow-up after LSD psychotherapy", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:47.561811+00:00"}
{"study_id": 24429, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers sought to test the effect of LSD on suggestibility and cued mental imagery in healthy volunteers.", "results_summary": "Volunteers gave significantly higher ratings for suggestibility (CIS) under LSD compared to placebo, but cued mental imagery (MIT) was unaffected. The suggestibility-enhancing effect of LSD was positively correlated with baseline trait conscientiousness.", "population_specificity": "Ten healthy volunteers", "effective_dosage": "40-80 \u03bcg intravenous (i.v.) LSD", "study_duration": "Single administration, assessments at 110 and 140 minutes post-infusion", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:47.700622+00:00"}
{"study_id": 24432, "supplement_id": 1303, "safety_score": "20", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the long-term behavioral and molecular effects of chronic LSD administration in rats, particularly its relevance to psychiatric illnesses like schizophrenia.", "results_summary": "Chronic LSD administration in rats led to persistent abnormal behaviors resembling schizophrenia, including hyperactivity and reduced social interaction. RNA-sequencing revealed widespread gene expression changes in the mPFC, affecting neurotransmission, synaptic plasticity, and energy metabolism, with overlap in genes implicated in schizophrenia.", "population_specificity": "Rats", "effective_dosage": "Not specified", "study_duration": "90 days (every other day administration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:49.043023+00:00"}
{"study_id": 24431, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of enzyme replacement therapy (ERT) for adults and children with Fabry disease.", "results_summary": "The study found a statistically significant association between ERT and a small linear decrease in left ventricular mass index (LVMI), reduced risk of proteinuria, and a small increase in estimated glomerular filtration rate (eGFR) in adults. No significant associations were found for pain, hearing, or stroke/TIA risk, and no effectiveness was demonstrated in children.", "population_specificity": "Adults (N=289) and children (N=22) with Fabry disease attending a specialist treatment center in England.", "effective_dosage": "Not specified", "study_duration": "Up to 9.7 years for adults, up to 4.2 years for children", "interactions": "Adjusted for angiotensin-converting enzyme inhibitors and angiotensin receptor blockers", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:49.308120+00:00"}
{"study_id": 24434, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the natural history of lysosomal storage disorders (LSDs) and estimate the effectiveness and cost of therapies for specific LSDs in the UK.", "results_summary": "The study collected clinical data from 711 patients with various LSDs but did not report specific findings in the abstract; results are detailed in condition-specific articles.", "population_specificity": "Adults and children in the UK with confirmed diagnoses of Gaucher disease, Fabry disease, MPS I, MPS II, Pompe disease, or NPC.", "effective_dosage": "Not mentioned", "study_duration": "Data was collected from 2008 to 2011 (3 years).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:52.444959+00:00"}
{"study_id": 24436, "supplement_id": 1303, "safety_score": "60", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to document cases of LSD-related flashbacks involving new visual imagery not experienced during initial intoxication.", "results_summary": "Two patients with prior LSD use reported benign flashbacks featuring new visual imagery, distinct from prior LSD experiences, which resolved spontaneously within a year without functional impairment.", "population_specificity": "Two patients with a history of LSD use experiencing HPPD.", "effective_dosage": "Not specified", "study_duration": "One-year follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:54.648948+00:00"}
{"study_id": 24435, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of enzyme replacement therapies (ERT) for adults with Gaucher disease (GD).", "results_summary": "The study found that ERT was associated with statistically significant improvements in platelet count, hemoglobin, liver and spleen volumes, and AST levels in adults with GD. These results support the long-term effectiveness of ERT for this condition.", "population_specificity": "Consenting adults (N=150, aged 16 to 83 years) with a diagnosis of GD who attended a specialist treatment center in England.", "effective_dosage": "Not specified", "study_duration": "Mean treatment duration was 10.8 years (range 0-18 years).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:55.713390+00:00"}
{"study_id": 24437, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether chronic treatment with the mGlu2/3 receptor antagonist LY341495 could reduce the hallucinogenic-like effects of LSD in mice.", "results_summary": "Chronic LY341495 treatment down-regulated 5-HT(2A) receptor binding and significantly decreased LSD-induced head-twitch behavior and gene expression (c-fos, egr-1, egr-2), suggesting reduced hallucinogenic effects.", "population_specificity": "Wild-type and mGlu2 knockout (KO) mice", "effective_dosage": "LSD (0.24 mg/kg), LY341495 (1.5 mg/kg)", "study_duration": "21 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:55.903392+00:00"}
{"study_id": 24438, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 65, "study_goal": "The researchers aimed to explore why LSD psychotherapy research declined in the 1960s, focusing on the challenges posed by controlled clinical trial requirements introduced by the 1962 Drug Amendments.", "results_summary": "The study found that LSD psychotherapy's complex methodology clashed with controlled trial designs, making it difficult to establish efficacy. The new emphasis on rigorous trial design diverted researchers' focus from therapeutic methods, contributing to the decline of LSD research.", "population_specificity": "Not specified (general discussion of historical LSD psychotherapy research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:56.743448+00:00"}
{"study_id": 24439, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of chronic clozapine treatment on LSD-induced cellular and behavioral responses in mice as a model of psychosis.", "results_summary": "Chronic clozapine reduced LSD-induced head-twitch response and downregulated 5-HT(2A) receptor binding and mRNA expression, with some effects persisting up to 14 days post-treatment. C-fos induction was rescued 7 days after clozapine, but LSD-specific markers (egr-1, egr-2) were unaffected.", "population_specificity": "Mice (somatosensory cortex focus)", "effective_dosage": "Not specified for LSD (clozapine: 25 mg/kg/day)", "study_duration": "21 days (clozapine treatment)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:26:58.182947+00:00"}
{"study_id": 24440, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical efficacy of LSD in treating alcoholism through a quantitative meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis found a beneficial effect of LSD on alcohol misuse (OR, 1.96; 95% CI, 1.36-2.84; p = 0.0003), with negligible heterogeneity between trials (I\u00b2 = 0%). A single dose of LSD, within various treatment programs, was associated with reduced alcohol misuse.", "population_specificity": "536 participants with alcoholism across six trials.", "effective_dosage": "Single dose (specific amount not detailed).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:00.897381+00:00"}
{"study_id": 24441, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the behavioral pharmacology of LSD, specifically its receptor binding properties and the role of 5-HT(2A) and D(1) receptors in eliciting head bob behavior in an animal model.", "results_summary": "The study found that LSD-elicited head bobs required activation of 5-HT(2A) and D(1) receptors, with LSD binding pseudo-irreversibly to 5-HT(2A) receptors and showing modest D(1) receptor affinity. These findings suggest a common mechanism for hallucinogen-induced behaviors.", "population_specificity": "Rabbits", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:02.639256+00:00"}
{"study_id": 24443, "supplement_id": 1303, "safety_score": "30", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to review the literature on LSD-associated rhabdomyolysis and present a new case report of a patient who developed rhabdomyolysis after LSD ingestion.", "results_summary": "The study found limited reports of rhabdomyolysis in patients who ingested LSD, despite it being frequently listed as a cause. The discussion outlines potential mechanisms and management strategies for LSD-associated rhabdomyolysis.", "population_specificity": "A previously healthy patient who suffered rhabdomyolysis after LSD ingestion (case report) and broader literature review.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:04.386127+00:00"}
{"study_id": 24444, "supplement_id": 1303, "safety_score": "20", "efficacy_score": null, "quality_score": 50, "study_goal": "The researchers aimed to report a rare case of ergotism related to LSD ingestion and describe an unconventional treatment for associated vasospasm.", "results_summary": "The study found that LSD ingestion led to ergotism and severe lower extremity vasospasm, which was treated with balloon percutaneous transluminal angioplasty. The abstract does not discuss LSD's intended effects or outcomes beyond this adverse event.", "population_specificity": "A single case of a patient with LSD-induced ergotism.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:04.517955+00:00"}
{"study_id": 24442, "supplement_id": 1303, "safety_score": "20", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the temporal phases of LSD intoxication in rats and assess whether chronic low-dose LSD administration could serve as an animal model of psychosis.", "results_summary": "The study found that LSD's effects in rats occur in two distinct phases mediated by different receptors (5-HT2A initially, D2-like later). Chronic LSD administration induced persistent psychosis-like behaviors, reversed transiently by antipsychotics, and altered neurotransmitter-related gene expression.", "population_specificity": "Rats (older and younger animals)", "effective_dosage": "0.16 mg/kg every other day", "study_duration": ">3 months", "interactions": "Haloperidol, olanzapine, MDL-100907 (mentioned for behavioral reversal or insensitivity)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:04.837075+00:00"}
{"study_id": 24427, "supplement_id": 1303, "safety_score": "50", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review LSD's history, pharmacology, and potential benefits in treating addictions.", "results_summary": "The study found that LSD has potential benefits for addiction treatment but also noted adverse effects leading to its classification as an illicit drug. Further research into its therapeutic potential is warranted.", "population_specificity": "Not specified (review of literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:04.885205+00:00"}
{"study_id": 24446, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 40, "quality_score": 30, "study_goal": "The researchers reviewed historical studies to assess how LSD was justified, its methods, results, and conclusions in treating children with autism.", "results_summary": "Several positive outcomes were reported with LSD use, but most studies lacked proper controls and relied on narrative/descriptive data. The justification for LSD use was often based on the failure of other treatments.", "population_specificity": "Children with autism.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:05.542019+00:00"}
{"study_id": 24447, "supplement_id": 1303, "safety_score": "30", "efficacy_score": null, "quality_score": 40, "study_goal": "The researchers aimed to describe a case of new-onset LSD flashback syndrome triggered by SSRIs in a patient with a history of LSD use.", "results_summary": "The study reported a troubling array of unusual side effects in a patient, which were postulated to be LSD flashbacks induced by SSRIs. No broader efficacy or safety conclusions about LSD were drawn.", "population_specificity": "A patient with a history of LSD use requiring antidepressant treatment.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "SSRIs (selective serotonin reuptake inhibitors)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:08.690620+00:00"}
{"study_id": 24433, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not address LSD; it examines the effectiveness of enzyme replacement therapies (ERT) for children with Gaucher disease (GD).", "results_summary": "The study found that ERT significantly improved platelet count, hemoglobin levels, and reduced bone pain in children with GD, with greater effects observed in GD3 patients compared to GD1.", "population_specificity": "Children aged 1.1 to 15.6 years with Gaucher disease (14 with GD1 and 11 with GD3).", "effective_dosage": "Not mentioned", "study_duration": "Mean treatment duration was 5.57 years (range 0-13.7 years).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:12.059081+00:00"}
{"study_id": 192988, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not mention LSD or its effects; it focuses on histone epigenetic modifications and cardiac metabolism disorders.", "results_summary": "The abstract does not discuss LSD or its effects; it reviews cardiac acetyl-CoA-dependent histone acetylation and NAD-related mechanisms.", "population_specificity": "Not specified (abstract does not mention LSD or a study population).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:12.249439+00:00"}
{"study_id": 192987, "supplement_id": 1303, "safety_score": "80", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the therapeutic potential of LSD and other psychedelics in treating mental disorders such as anxiety, affective disorders, and addictions.", "results_summary": "Preliminary studies showed promising therapeutic effects of LSD and psilocybin when used as a supplement to psychotherapy, with no serious side effects reported. However, further large-scale studies are needed to confirm these findings and assess practical applications.", "population_specificity": "Not specified (general mention of mental health applications).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:12.903976+00:00"}
{"study_id": 24449, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate LSD's effects on dopamine D2/3 receptor availability in living brain tissue and its potential contribution to LSD's psychoactive properties.", "results_summary": "The study found a 19% reduction in dopamine D2/3 receptor binding potential in pig striatum 4 hours after LSD administration, suggesting a direct interaction. No significant changes in cerebral blood flow or interstitial dopamine concentrations were observed.", "population_specificity": "Pigs (in vivo PET study) and rat brain tissue (in vitro microdialysis).", "effective_dosage": "2.5 \u00b5g/kg, intravenous (single dose).", "study_duration": "Acute administration with measurements at 1 and 4 hours post-dose.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:12.957343+00:00"}
{"study_id": 24451, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 20, "study_goal": "The researchers aimed to assess the effects of risperidone treatment in schizophrenic patients with prior LSD abuse and evaluate transient visual disturbances resembling LSD \"flashbacks.\"", "results_summary": "Two schizophrenic patients with prior LSD abuse experienced transient visual disturbances resembling LSD flashbacks after starting risperidone, but these resolved without recurrence over six months. The study suggests this is a benign, self-limiting side effect that does not contraindicate risperidone use.", "population_specificity": "Schizophrenic patients with a history of LSD abuse and prior EPS from classic antipsychotics.", "effective_dosage": "Not specified", "study_duration": "Six-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:13.040683+00:00"}
{"study_id": 24448, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a combination of NT-3 and LSD could facilitate functional recovery in rats with spinal cord injuries.", "results_summary": "The study found that NT-3 + LSD treatment improved polysynaptic connections and behavioral outcomes (hindlimb kicks and rearing) in rats with spinal cord injuries, while neither NT-3 nor LSD alone had an effect. Improvements were observed as early as P9 and persisted through testing.", "population_specificity": "Postnatal day 2 (P2) rats with spinal cord injuries (double hemisection or complete transection).", "effective_dosage": "Intrathecal administration during surgery and subcutaneous doses at P4, P6, P8, and P10 (exact amounts not specified).", "study_duration": "Intervention administered from P2 to P10, with behavioral testing up to P58.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:13.673074+00:00"}
{"study_id": 192989, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to investigate whether naturalistic psychedelic use (primarily LSD and psilocybin) could lead to cessation or reduction in problematic alcohol use among individuals with prior alcohol use disorder (AUD).", "results_summary": "The study found that 83% of participants no longer met AUD criteria after a psychedelic experience, with significant reductions in alcohol consumption. Greater psychedelic dose, insight, mystical-type effects, and personal meaning of experiences were associated with greater reductions in alcohol use.", "population_specificity": "Individuals with prior AUD (72% severe AUD), mostly White (89%), male (78%), and from the USA (60%).", "effective_dosage": "Moderate or high doses of LSD (38%) or psilocybin (36%).", "study_duration": "Not specified (retrospective survey).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:18.481573+00:00"}
{"study_id": 192990, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were attempting to determine the relationship between relative and absolute internal and external loads in collegiate basketball players using tensiomyography and accelerometry, with LSD pairwise comparisons for statistical analysis.", "results_summary": "The study found significant differences in absolute external loads (PlayerLoad\u2122 and IMA\u2122) and meaningful relative load changes between weeks, suggesting tensiomyography may better detect fatigue from relative external load changes than absolute loads.", "population_specificity": "Five Division I collegiate basketball players.", "effective_dosage": "Not mentioned", "study_duration": "The 2015-2016 basketball season.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:20.547451+00:00"}
{"study_id": 192991, "supplement_id": 1303, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to highlight the hepatic manifestations of lysosomal storage diseases (LSDs) in adults and emphasize diagnostic and therapeutic approaches.", "results_summary": "The study found that LSDs, such as Gaucher disease and Niemann-Pick diseases, often present with mild hepatomegaly and splenomegaly but rarely progress to severe liver complications. Effective treatments like enzyme supplementation and substrate deprivation are available for some LSDs, such as Gaucher disease.", "population_specificity": "Adults with suspected or diagnosed lysosomal storage diseases, particularly those presenting with hepatic symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:20.803352+00:00"}
{"study_id": 23973, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to systematically review existing studies on the effects of lutein on neurodegenerative diseases, focusing on its potential as a complementary treatment.", "results_summary": "The review found mixed results, with 4/17 studies showing improved cognitive function, 8/17 indicating reduced progression of Alzheimer's disease, and 2/17 noting improved lipid profiles, while some studies found no significant associations.", "population_specificity": "Studies included patients with Alzheimer's disease (14 studies), Parkinson's disease (2 studies), and Amyotrophic lateral sclerosis (1 study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:21.274916+00:00"}
{"study_id": 23974, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of alkaline electrolyzed water (AEW)-assisted ultrasonic extraction in preserving lutein's structure and bioactivity, particularly its ability to protect against blue light-induced retinal damage.", "results_summary": "AEW extraction increased lutein yield by 60% and preserved its all-trans form, enhancing antioxidant capacity. Lutein extracted using AEW significantly improved ARPE-19 cell viability and intracellular antioxidant enzyme activity, mitigating oxidative stress from blue light exposure.", "population_specificity": "ARPE-19 cells (a human retinal pigment epithelial cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:21.938079+00:00"}
{"study_id": 23976, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of lutein as a hepatoprotective agent for treating intestinal failure-associated liver disease (IFALD), focusing on its antioxidant and anti-inflammatory properties.", "results_summary": "The study highlights lutein's hepatoprotective effects, supported by evidence from cell and animal studies exposed to liver-damaging factors like lipopolysaccharide, high-fat diet, and alcohol. It suggests lutein could be a promising therapeutic option for IFALD, particularly in patients with nutrient deficits due to parenteral nutrition.", "population_specificity": "Patients with intestinal dysfunction, particularly premature neonates and infants on long-term parenteral nutrition.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:22.001882+00:00"}
{"study_id": 23977, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the impact of pH and heat treatment on the binding affinity between caseinates and lutein/zeaxanthin, and evaluate caseinates as protective carriers for xanthophyll-fortified beverages.", "results_summary": "Caseinates bound effectively to lutein and zeaxanthin, with zeaxanthin showing higher affinity. Lower pH and preheating strengthened binding, improving lutein/zeaxanthin stability and achieving over 70% bioaccessibility.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:22.139311+00:00"}
{"study_id": 23979, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether oral lutein could improve fat graft retention by reducing oxidative stress, inflammation, and apoptosis in grafted fat.", "results_summary": "Lutein improved graft retention, reduced oxidative stress and lipid damage, decreased inflammation and apoptosis, and downregulated related gene expression.", "population_specificity": "Nude mice", "effective_dosage": "10 mg/kg/day (low dose) and 20 mg/kg/day (high dose)", "study_duration": "1 week pre-treatment and 2 weeks post-treatment (total 3 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:28.817990+00:00"}
{"study_id": 23981, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effect of lutein-loaded nanoparticles on Drosophila melanogaster offspring exposed to imidacloprid-induced neurodevelopmental damage.", "results_summary": "Lutein-loaded nanoparticles reversed behavioral and biochemical markers of neurodevelopmental disorders, including hyperactivity, social interaction deficits, and oxidative stress, while restoring Nrf2 and Shank3 immunoreactivity.", "population_specificity": "Drosophila melanogaster (fruit fly) offspring exposed to imidacloprid.", "effective_dosage": "Not specified", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:28.988681+00:00"}
{"study_id": 23980, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of Cordycepin (COR) on STAR expression in ovarian granulosa cells and its underlying mechanisms.", "results_summary": "COR downregulated STAR expression in both KGN cells and primary human granulosa-lutein cells by reducing SP1 transcription factor expression, mediated via AR-A1, AR-A2A, and AR-A3 receptors, and involving ERK1/2 signaling.", "population_specificity": "Human granulosa-like tumor cell line (KGN) and primary human granulosa-lutein cells from IVF patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:29.172121+00:00"}
{"study_id": 23984, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the impact of ultrasound-treated multilayer emulsions on the stability and retention of lutein under various conditions.", "results_summary": "The study found that ultrasound treatment significantly improved the emulsion's stability and increased lutein retention by 21.88% after high-temperature exposure and 19.35% after UV irradiation. The emulsion also demonstrated prolonged release behavior.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:29.866609+00:00"}
{"study_id": 23983, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether supplementation with lutein, zeaxanthin, and meso-zeaxanthin could reduce systemic inflammation and lipid oxidation markers linked to atherosclerosis.", "results_summary": "The study found that supplementation significantly increased serum carotenoid levels, reduced inflammatory cytokines (IL-1\u03b2 and TNF-\u03b1), and lowered oxidized LDL, suggesting systemic anti-inflammatory and antioxidative effects.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Lutein (10 mg) + meso-zeaxanthin (10 mg) + zeaxanthin (2 mg) daily.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:30.745682+00:00"}
{"study_id": 23982, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 78, "quality_score": 82, "study_goal": "The researchers aimed to investigate the impact of lutein-loaded PLGA nanoparticles on lens epithelial cell viability, reactive oxygen species reduction, and cataract prevention in rodents.", "results_summary": "Lutein-loaded nanoparticles (LNP) significantly reduced reactive oxygen species and cataract scores in rodents, with minimal impact on cell viability at concentrations < 0.2 \u03bcg/\u03bcl. Topical LNP treatment showed effective lutein delivery to the anterior eye segment without causing keratitis or uveitis.", "population_specificity": "Rodents (selenite-induced cataract model)", "effective_dosage": "Equivalent lutein concentration of 1,278 \u03bcg/mL (topical, once daily)", "study_duration": "One week", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:30.949722+00:00"}
{"study_id": 23985, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the outcomes of lutein supplementation in mothers and infants, its status and metabolism during pregnancy and lactation, and potential limitations in its application as a nutritional intervention.", "results_summary": "Lutein supplementation improved lutein status in infants, but its bioavailability is low, limiting its effectiveness. Encapsulation techniques may enhance delivery but require further evaluation in neonatal models.", "population_specificity": "Pregnant and lactating women, preterm and formula-fed infants, and term and breast-fed infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:37.394539+00:00"}
{"study_id": 23986, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether lutein improves HDL functionality, specifically cholesterol efflux capacity (CEC), LCAT activity, and PON1 activity, under various disease-associated chemical stressors.", "results_summary": "Lutein improved HDL cholesterol efflux capacity (CEC) and PON1 activity but reduced LCAT activity and median HDL particle diameter. It showed protective effects against oxidative and glycation-related HDL dysfunction.", "population_specificity": "Generally healthy human plasma-derived HDL samples.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:37.554746+00:00"}
{"study_id": 23987, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of IL-1 cytokines (IL-1\u03b1 and IL-1\u03b2) in the pathogenesis of PCOS and their effects on human granulosa-lutein (hGL) cells.", "results_summary": "The study found increased levels of IL-1\u03b1 and IL-1\u03b2 in follicular fluid from PCOS patients, which induced inflammatory responses in hGL cells and upregulated SERPINE1 expression via IL-1R1-mediated signaling pathways.", "population_specificity": "PCOS patients and primary human granulosa-lutein (hGL) cells.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:38.094166+00:00"}
{"study_id": 23988, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether lutein-loaded Pickering emulsions could improve the bioaccessibility of lutein and alleviate retinal thinning in mice with dry age-related macular degeneration (dAMD).", "results_summary": "The study found that lutein-loaded Pickering emulsions improved lutein retention and bioaccessibility (19.76%-53.34%) and effectively reduced retinal thinning in mice with dAMD by decreasing oxidative stress markers (MDA, ROS) and increasing SOD production.", "population_specificity": "Mice with sodium iodate (NaIO3)-induced dry age-related macular degeneration (dAMD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:38.437688+00:00"}
{"study_id": 23989, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of low and high doses of lutein on memory and synaptic function in rats with vascular dementia induced by bilateral-carotid vessel occlusion.", "results_summary": "Both low and high doses of lutein improved spatial memory and long-term potentiation (LTP) impairment, but only the high dose restored fear memory, hippocampal cell loss, volume, and MDA levels. Low-dose lutein increased neurotransmitter release probability, while high-dose affected postsynaptic processes.", "population_specificity": "Bilateral-carotid vessel occlusion (2VO) rats as a model for vascular dementia.", "effective_dosage": "0.5 mg/kg (low dose) and 5 mg/kg (high dose).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:40.121164+00:00"}
{"study_id": 23990, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate how EGF-like factors (AREG, BTC, EREG) influence PTX3 expression and production in human granulosa-lutein (hGL) cells and the underlying molecular mechanisms.", "results_summary": "The study found that AREG, BTC, and EREG upregulated PTX3 expression and production in hGL cells via the ERK1/2 signaling pathway, which was reversed by EGFR inhibition or knockdown, suggesting a role in modulating cumulus expansion during ovulation.", "population_specificity": "Human granulosa-lutein cells obtained from 20 consenting patients undergoing IVF treatment, as well as immortalized hGL cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:40.262298+00:00"}
{"study_id": 23978, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether controlled thermal and trypsin treatments of soy protein isolate (SPI) could improve encapsulation efficiency and storage stability of lutein.", "results_summary": "The study found that SPI trypsin hydrolysates (SPIT) significantly improved lutein encapsulation efficiency (12.00-18.59% increase) and photostability (38.21% increase for SPIT2), attributed to enhanced hydrophobic group exposure, antioxidant activity, and particle stability.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:41.759639+00:00"}
{"study_id": 23991, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to critically assess lutein biosynthesis, therapeutic applicability, and market potential, focusing on its effects on age-related macular degeneration, diabetic retinopathy, inflammation, and other ailments.", "results_summary": "Lutein significantly lowers incidences of age-related macular degeneration, has anti-inflammatory effects, and improves visual contrast. It is an essential nutrient with antioxidant properties but faces challenges in production and extraction, making it expensive despite high demand.", "population_specificity": "Not specified (general human population inferred)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:45.692993+00:00"}
{"study_id": 23993, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the neuroprotective properties of lutein against Alzheimer's disease (AD) and Parkinson's disease (PD) and discuss strategies to improve its bioavailability.", "results_summary": "The study found that lutein exhibits neuroprotective properties against AD and PD due to its high antioxidant potential and selective accumulation in the brain. Clinical and model system observations support its potential in managing neurodegenerative diseases, though bioavailability remains a concern.", "population_specificity": "Not specified (review of various model systems and clinical observations)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:46.244304+00:00"}
{"study_id": 23992, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of jet-milling and pulsed electric field (PEF) on lutein extraction and preservation in spinach powder and juice.", "results_summary": "Superfine spinach powder (SP-superfine) had the highest lutein content, and PEF treatment preserved lutein levels better than thermal treatment during storage. SP-superfine with PEF also showed the highest antioxidant activities.", "population_specificity": "Spinach powder and juice (no human or animal subjects mentioned).", "effective_dosage": "Not specified (study focused on processing methods).", "study_duration": "25 days (storage period).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:46.566374+00:00"}
{"study_id": 23994, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the optimal processing sequence (ultrasound followed by ethanol treatment) for improving the physicochemical properties of soy protein isolate (SPI) to enhance the stability and bioaccessibility of lutein in SPI-lutein nanoparticles.", "results_summary": "The study found that the sequence of ultrasound followed by ethanol treatment produced smaller, more stable nanoparticles with improved lutein loading. The bioaccessibility of lutein increased significantly (from 25.48% to 65.85%) and its release rate was modulated during gastrointestinal digestion.", "population_specificity": "Not specified (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:48.009897+00:00"}
{"study_id": 23997, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers were presenting a case study of a young unmarried female with a hydatidiform mole (HM) and theca lutein cysts, not investigating Lutein's effects.", "results_summary": "The abstract describes the characteristics, symptoms, and management of theca lutein cysts associated with molar pregnancy but does not report any findings related to Lutein.", "population_specificity": "Young unmarried female with HM and theca lutein cysts.", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:48.728273+00:00"}
{"study_id": 23996, "supplement_id": 1305, "safety_score": "95", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether supplementation with lutein and zeaxanthin could improve visual and cognitive function in preadolescent children.", "results_summary": "The study found that lutein and zeaxanthin supplementation significantly increased macular pigment optical density, serum levels of lutein and zeaxanthin, and brain-derived neurotrophic factor (BDNF), while also improving cognitive performance, reducing eye strain and fatigue, and enhancing visual processing speed. No safety concerns were observed.", "population_specificity": "Preadolescent children aged 5-12 years.", "effective_dosage": "10 mg lutein and 2 mg zeaxanthin daily.", "study_duration": "180 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:49.192450+00:00"}
{"study_id": 23998, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the impact of sunlight intensity on intracellular lutein production and phosphorus removal by an autoflocculating microalgae consortium in secondary effluents.", "results_summary": "The microalgae produced significantly more lutein (2.91 mg g-1) under low light conditions, demonstrating antioxidant activity, while maintaining high phosphorus removal (above 85%) and autoflocculation rates (98%).", "population_specificity": "Autoflocculating microalgae consortium BR-UANL-01 grown in secondary effluents from a wastewater treatment plant.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:49.932208+00:00"}
{"study_id": 23999, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of BMP-9 in regulating StAR expression and its molecular mechanisms in human granulosa-lutein (hGL) cells.", "results_summary": "BMP-9 downregulated StAR expression in hGL cells and upregulated EMT-related transcription factors Snail and Slug via SMAD1/5/8 signaling, with only Snail being necessary for StAR downregulation.", "population_specificity": "Human granulosa-lutein (hGL) cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:53.606557+00:00"}
{"study_id": 24002, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining lutein (LUT) with epigallocatechin-3-gallate (EGCG) could improve retinitis pigmentosa (RP) outcomes compared to LUT alone.", "results_summary": "The LUT-EGCG combination significantly increased lutein accumulation in the liver, improved retina structure, boosted short-chain fatty acid production, and modulated gut microbiota and antiapoptotic gene expression compared to LUT alone. It also downregulated IL-6 but showed no significant effects on other inflammatory markers.", "population_specificity": "N-methyl-N-nitrosourea (MNU)-induced mouse model of retinitis pigmentosa.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:56.475742+00:00"}
{"study_id": 24003, "supplement_id": 1305, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of a biomimetic drug delivery system (MMLNPs) for improving lutein's bioavailability and targeting capability in treating hypertensive heart disease and cardiac fibrosis.", "results_summary": "The study found that MMLNPs effectively targeted injured hearts, inhibited cardiac fibroblast proliferation, improved cardiac function and structure, and reduced fibrosis by suppressing the IL-11/ERK signaling pathway, with no observed biological toxicity.", "population_specificity": "Transverse aortic constriction (TAC) model mice and in vitro studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:56.528019+00:00"}
{"study_id": 24000, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of lutein/zeaxanthin (L/Z) and quercetagetin (QCG) against LED-induced retinal damage in rats.", "results_summary": "L/Z and QCG, especially in a 1:1 combination at 20 mg/kg, reversed LED-induced retinal damage by reducing oxidative stress and inflammation while enhancing neuroplasticity markers and retinal thickness. The treatment suppressed harmful markers (NF-\u03baB, ICAM, GFAP, MCP-1) and boosted protective factors (Nrf2, HO-1, GAP43, NCAM).", "population_specificity": "Wistar rats (n = 63, divided into 9 groups of 7).", "effective_dosage": "L/Z (10 or 20 mg/kg BW), QCG (10 or 20 mg/kg BW), or a combination.", "study_duration": "28 days of supplementation followed by 48 hours of LED exposure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:57.790147+00:00"}
{"study_id": 24004, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to develop stable, dual-responsive liposomes (Dr-lips) using lutein (L) for targeted drug delivery of chlorin e6 (Ce6) and paclitaxel (PTX) in cancer treatment.", "results_summary": "The Dr-lips exhibited excellent stability, high drug encapsulation rates (92.27% for PTX and 90.34% for Ce6), and demonstrated pH and photo dual-responsiveness for targeted drug release. They also showed remarkable ROS generation capacity and anti-tumor activity in vitro.", "population_specificity": "In vitro (laboratory study, no human or animal subjects specified).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:57.874026+00:00"}
{"study_id": 24006, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the efficacy of 4-month lutein supplementation on carotenoid status and cognition in individuals with relapse-remitting MS (RRMS).", "results_summary": "Lutein supplementation significantly improved carotenoid status (MPOD, skin carotenoids, and serum lutein) but did not significantly affect cognitive function. However, increased macular carotenoids were selectively associated with improved attention and memory in the treatment group.", "population_specificity": "Adults with relapse-remitting MS (RRMS) (N = 21).", "effective_dosage": "20 mg/d lutein.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:27:58.169508+00:00"}
{"study_id": 24007, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether oral lutein and zeaxanthin supplementation positively affects the FLIO signal in patients with early and intermediate AMD.", "results_summary": "The study found that supplementation significantly increased serum lutein and zeaxanthin concentrations, improved MPOD, and reduced FLIO lifetimes in the foveal center, with effects reversing after supplementation ended. A significant negative correlation between FLIO and MPOD was confirmed.", "population_specificity": "Patients with early and intermediate age-related macular degeneration (AMD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Three months of supplementation, followed by three months of observation post-therapy.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:03.539554+00:00"}
{"study_id": 24009, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether betacellulin (BTC) regulates connexin 43 (Cx43) phosphorylation and gap junction intercellular communication (GJIC) activity in human granulosa-lutein (hGL) cells.", "results_summary": "BTC induced rapid phosphorylation of Cx43 at serine368, leading to decreased GJIC activity in hGL cells, mediated primarily by EGFR and downstream PKC signaling. The study did not alter Cx43 expression levels.", "population_specificity": "Primary and immortalized human granulosa-lutein cells from women undergoing in vitro fertilization.", "effective_dosage": "Not specified", "study_duration": "Different time points (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:05.220293+00:00"}
{"study_id": 24012, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of magnetic drug targeting using lutein-loaded nanoparticles for enhanced cytotoxicity against breast cancer cells.", "results_summary": "The optimized lutein-loaded nanoparticles exhibited controlled size, superparamagnetism, and significantly enhanced cytotoxicity (4-fold increase) against MCF-7 breast cancer cells compared to free lutein when exposed to a magnetic field. The nanoparticles were biocompatible and demonstrated sustained-release properties.", "population_specificity": "Breast cancer MCF-7 cells (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:05.998332+00:00"}
{"study_id": 24013, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the antitumorigenic effects of lutein on non-small cell lung cancer (NSCLC) cells and elucidate its underlying molecular mechanisms.", "results_summary": "Lutein significantly inhibited NSCLC cell proliferation, induced cell cycle arrest at the G0/G1 phase, and promoted apoptosis by activating the ATR/Chk1/p53 signaling pathway. In vivo, lutein reduced tumor growth and prolonged survival in mice.", "population_specificity": "Non-small cell lung cancer (NSCLC) cells (A549) and mouse models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:06.391794+00:00"}
{"study_id": 24005, "supplement_id": 1305, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to confirm the antioxidant, antiviral, and anti-inflammatory effects of Tetraselmis sp. extract (TEE), which contains lutein.", "results_summary": "TEE demonstrated significant antioxidant, antiviral, and anti-inflammatory effects, including scavenging free radicals, reducing viral plaque formation, inhibiting nitric oxide production, and lowering proinflammatory cytokine release via MAPKs and NF-\u03baB pathways. High-performance liquid chromatography confirmed a strong presence of lutein in TEE.", "population_specificity": "In vitro (Vero E6 cells, RAW264.7 cells) and in vivo (zebrafish model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:28:07.384680+00:00"}
